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INTRODUCTION

This dissertation project sought to determine the relationship between
function and structure of the transmitter domain of the chemotaxis-associated
histidine autokinase CheA of Eschericia coli.

For some time, the transmitter

domain of CheA has been proposed as the site of ATP binding and hydrolysis
on the basis of homology to eukaryotic serine/threonine kinases. Here, I have
tested this hypothesis, establishing that the transmitter region of CheA does act
as the catalytic site.
First, I used site-directed mutagenesis to introduce conservative amino
acid changes in the highly conserved regions of the putative catalytic domain of
CheA. I then examined their ability to mediate chemotaxis and in the process
demonstrated that changes in the most conserved residues of this domain
completely eliminated chemotaxis.
Second, I purified these mutant CheA proteins and tested their ability to
autophosphorylate (a measure of their capacity to bind and hydrolyze ATP).
None of the CheA mutants tested autophosphorylated despite prolonged
exposure to ATP. In collaboration with Rick Stewart (University of Maryland),
we next determined that a CheA protein mutated in the first of two glycine-rich

1

2

regions bound the ADP analog TNP-ADP poorly ie., with about a 10-fold
decrease in affinity relative to that of the wild-type protein. In contrast, a CheA
protein mutated in the second glycine-rich regions bound TNP-ADP about as
well as did the wild-type CheA protein. Although point mutations within this
second glycine-rich region exerted no effect upon its ability to bind TNP-ADP,
eliminating the entire region caused about a 3-fold decrease in affinity. A
protein mutated in both glycine-rich regions bound TNP-ADP about 2 times less
efficiently than did a protein mutated in the first glycine-rich region.Thus,
although this region may not play a direct role in binding TNP-ADP, it does
influence binding by the first glycine-rich region.
Third, I examined each of the mutants for their ability to be complemented
with an intact putative catalytic domain supplied in trans by CheA 8 , a natural
variant of CheA that lacks the site of autophosphorylation. In vitro, CheA8
complemented all of the CheA mutants tested. In vivo, CheA8 complemented
CheA proteins mutated in either of the glycine-rich regions, but not those
defective in both of the glycine-rich regions or deleted for the second one.
Since transphosphorylation in vitro of these latter two mutant proteins was
significantly reduced relative to that of mutants defective for one glycine-rich
region or the other, these results support the hypothesis that CheA
autophosphorylation must reach a certain threshold level before chemotaxis
can occur in vivo. CheA proteins mutated in G 1 or G2 cannot complement each
other in vivo or transphosphorylate each other in vitro suggesting that the G 1-
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F-G2 regions in a CheA dimer function independently and in cis within each
protomer.
Fourth, I examined the putative catalytic domain of CheA with computer
algorithms designed to predict secondary structure. On the basis of these
structure-averaging algorithms, I propose that the catalytic region might best be
represented as a cleft in which the F subdomain lies at the base and acts as a
flexible turn or hinge flanked by two short alpha helices. This arrangement
would serve to approximate G1 and G2, predicted to be unstructured
ATP-binding loops. The binding of ligand by the chemoreceptor would initiate a
cascade through the ternary complex with the end result being the movement of
the G 1 and G2 loops apart, rendering CheA in an "open" or inactive
conformation (Fig 20). To test this hypothesis, NMR analysis and x-ray
crystallographic analysis is required.

CHAPTER2
LITERATURE REVIEW

Sense and Response
All of life is connected by common needs. Among life's enormous
divergence, there exist fundamental systems and behaviors which bind the
simplest to the most complex. For instance, to survive and prosper, all cells,
from the simplest form of bacteria to the most complicated eukaryote, must
perform two tasks very well. First, they must sense their environment. Second,
they must be able to respond to what they sense.
A eukaryotic cell senses its environment primarily through the use of
proteins located on its surface and within its interior. Messages from the
exterior of the cell are conveyed to the interior by physical interaction of the cell
surface proteins with cytoplasmic proteins and with other cell surface proteins.
Although simple in comparison to eukaryotic cells, bacteria sense their
environment in much the same way.
The life of a bacterial cell is a precarious one. It must live in an
environment which is often hostile and dangerous, requiring that it respond
rapidly to unexpected extremes of nutrient supply, temperature, pH, and acidity.
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Bacteria are particularly adept at adapting to extremes. In fact, bacteria have
been so successful at adaptation, that they survive in a wide range of
environments that would be much too extreme for most eukaryotic cells. For
example, bacterial cells have been found thriving in the cooling tanks of nuclear
reactors and in super hot volcanic vents. To cope with such extremes, bacteria
have developed a wide array of specialized systems for sensing, interpreting
and responding to changes in their extracellular environment. They have
evolved a range of complex responses to environmental stresses. One such
response occurs when an E. coli cell encounters an increase in osmolarity of
the surrounding environment. In response, an inner membrane protein called
EnvZ autophosphorylates before passing that phosphate to a cytoplasmic
protein (OmpR).

In its phosphorylated state, OmpR binds DNA, increasing

transcription of one outer membrane porin and decreasing that of another. This
response allows the cell to optimize its internal salt concentration (Alphen and
Lugtengerg, 1977; Forst and Inouye, 1988). Phosphorylated OmpR also
influences the expression of the entire flagellar regulon (Shin and Park, 1995).
The response could also be far more complex, such as the formation of spores
by Bacillus subtilis (Burbulys et al., 1991 ), fruiting body formation in
microorganisms such as Myxococcus xanthus (Zusman and McBride, 1991), or
the chemotactic response by Eschericia coli (Mutoh and Simon, 1986).
Chemotaxis and the Flagellum in Eschericia coli
Chemotaxis is the process whereby a bacterium senses the presence of
attractants or repellents in its environment and responds by altering its
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swimming behavior. Some cells sense and respond to the concentration of
attractant in a highly directional manner, basing its direction of movement upon
where the stimulus occurred on the surface of the cell. Lymphocytes of the
mammalian immune system move in this fashion, altering their direction of
movement toward the point of the stimulus in the cellular membrane. This type
of "spatial" sensing relies upon the cells ability to calculate the difference in the
concentration of attractant at the point of the stimulus from the concentration of
attractant at a point opposite the stimulus and modify its direction accordingly.
A bacterium such as E. coli , however, senses the concentration of attractants
continuously in a temporal rather than spatial manner (Macnab and Koshland,
1972). An E. coli cell must sense temporally both because of its small size and
because it can sense changes in ligand concentration even when the
concentration of ligand is spatially homogeneous (Berg and Purcell, 1977;
Macnab and Koshland, 1972). This type of sensing is non-directional: it does
not matter if the attractant is being sensed at one end of the cell versus the
other. If attractants were sensed spatially by E. coli, the origin of the stimulus
would always point in the direction of swimming.

E. coli swims in a fluid environment by the use of propellor-like structures
called flagella. At the base of each flagellum is a motor that rotates alternately
counterclockwise (CCW) and clockwise (CW). Because of the shape and
periodicity of its flagella, E. coli is able to bundle all of its flagella into a single
helical unit which works in concert to propel the cell forward in a smooth gently

7
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RUN
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I
Fig 1. The "run" and "tumble" response. Illustration of the
relationship between direction of flagellar rotation and swimming
behaviors displayed by cells of E. coli. Counterclockwise (CCW)
rotation corresponds to runs; clockwise (CW) _rotation corresponds
to tumbles.
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curving path called a "run". This behavior occurs when the motors rotate CCW.
The cell changes direction by simply reversing some of its motors, causing them
to rotate in the CW direction. This action causes the flagellar bundle to jam, the
flagella fly apart and, working at cross-purposes, the cell executes a flailing
behavior called a ''tumble" until the motors re-assume the CCW direction of
rotation causing the bundle to reform (Fig. 1).
How does an E coli cell use seemingly random tumbles to swim toward
a better life? E. coli is an "optimist" and is constantly in search of a "better life"
(Berg 1983). When swimming in a liquid environment, et is constantly sensing
and calculating the concentration of attractants and repellents it encounters
(Berg and Purcell 1977). When the cell swims up a gradient of attractant, it
suppresses the next tumble. By contrast, if it swims down that gradient, the next
tumble occurs. Thus, runs in favorable directions are twice as long as those in
unfavorable directions.
The Flagellar Complex
E. coli is an enteric organism of the human gut, where it exists in a
commensal relationship with its host. The digestive tract of humans is limited in
its ability to break down many nutrients. Bacteria serve as an aid to promote
conversion of many indigestible nutrients into forms the host can metabolize.
Chemotaxis is an expensive undertaking in the context of energy consumption.
The energy expenditure is, however, justifiable under a variety of conditions. In
the environment external to the host, the flagellar complex may be needed for

9

Fig 2. The flagellar complex. (Adapted from Macnab, 1996)
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the purpose of finding nutrients and escaping toxins. But, in the nutrient-rich
environment of the gut, a flagellated cell may act as a virulence factor,
facilitating attachment and entry into preferred environments. When it becomes
necessary to produce a flagellum, E. coli initiates, through a number of
operons, the coordinate synthesis of all of the components necessary for its
construction. The flagellum is a complex structure that can be divided into three
main structural components; the extended basal body, the hook, and the
filament. Expression of the flagellar genes is performed in a hierarchical
fashion (Kutsukake and lino, 1994., Macnab, 1992). The actual assembly of the
flagellum is conducted sequentially with the basal body being constructed first,
followed by the hook, and then the filament (Fig 2).

The basal body : The basal body traverses the inner and outer
membranes and is anchored to the rigid cell wall. Elegant isolation techniques
and electron microscopic studies have revealed a structurally complex
organelle composed of a number of distinct structural features. The extended
basal body is the portion of the organelle lying on the inside of the inner
membrane and is called the "C" ring. This ring, composed of three proteins
called FliG, FliM, and FliN, is the switching apparatus responsible for
controlling rotational direction of the motor. This switch in direction is made in
response to interaction with the phosphorylated chemotaxis protein CheY,
described below (Francis et al., 1994).
The parts of the flagellar motor that comprise the actual turning apparatus
of the flagellar motor is composed of a number of interacting structural
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components

Above the C ring and traversing the inner membrane, cell wall,

and outer membrane are the MS ring (FliF), the proximal rod (FliB, FlgC, and
FlgF), the P and L rings (Flgl and FlgH), and the distal rod. The MS ring and the
Rod are spinning regions of the motor, while the L and P rings are thought to
act as a sort of flange, anchoring the basal body to the cell wall.
MotA and MotB: The flagellar motor is driven by proton motive force.

The protons needed to rotate the motor are supplied via a proton channel
composed of two proteins called MotA and MotB (Zhou et al., 1995). Mutants
in the Mot proteins are characterized as "paralyzed", meaning the motor does
not spin. This suggests that these proteins are directly involved in conduction of
protons across the membrane to drive the motor (Blair and Berg, 1990; Block
and Berg, 1984). Although not an integral part of the basal body structure, MotA
and MotB surround the basal body. They act as the stator for the flagellar motor
and are essential for motility.

Both proteins span the entire inner membrane.

Whereas MotA contains a substantial cytoplasmic interface, MotB contains a
peptidoglycan binding domain (Dean et al., 1984). The precise mechanism of
proton movement through the channel is not known. However, several residues
critical to channeling protons through MotA and MotB have been identified
(Sharp et al., 1995; De Mot and Vanderleyden, 1994).
The hook: The hook (FlgE) assembly is a highly flexible link between

the basal body and the filament. Its function is similar to that of a U-joint on a
car. The hook both allows the filament to rotate on a different plane than the
basal body motor and allows several flagella to bundle into a uniform complex.
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The helical wavelength of the hook is different from that of the filament despite
having the same nine fibril structure (Morgan et al., 1993). This allows flexibility
not possible with the more rigid filament structure (Block et al., 1989; Block et
al., 1991 ). Without this important component, all of the flagellar components
would have to be located within a small region to enable the flagella to form a
bundle.

The filament: The filament is the structural assembly which acts like a
propeller, giving the cell the ability to swim through a fluid environment. This
structure is composed entirely of a single protein subunit called flagellin (FliC)
(Kuwajima et al., 1986). When observed at high magnification, the filament can
be seen to possess a periodicity (a sine wave pattern) of about 0.5 µm (Kamiya
et al., 1982). When the motor is rotating in its default CCW direction, the flagella
group together in a single bundle and allow the cell to swim in a forward
direction.
The Chemotaxis Pathway
Chemotaxis in E coli and other microorganisms is dependent upon the
ability of chemoreceptors to communicate with switch components of flagellar
motors to modulate swimming behavior in response to the cells' chemical
environment. This communication requires the cooperative effort of the
cytoplasmic gene products of six genes, cheW, cheR, cheB, cheY, cheZ and
cheA (Mutoh and Simon 1986; Stock and Stock, 1987). Additionally, E coli

encodes 5 transmembrane chemoreceptors also known as transducers or
methyl-accepting chemotaxis proteins (MCP's). They are Tar (Clark and
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Koshland, 1979), Tsr (Hedblom and Adler, 1980), Tap (Manson et al., 1986),
Trg (Adler et al., 1973), and the recently described Aer (aerotaxis) (Bibikov and
Parkinson, Johnson and Taylor, personal communication). Tar and Tsr, the two
most extensively studied chemoreceptors, sense the amino acids aspartate and
serine, respectively.
The Excitatory Response
Chemotaxis is typically discussed in terms of two response mechanisms,
excitation and adaptation. When cells determine that the concentration of
attractant has increased or the concentration of repellent has decreased, they
respond by increasing the length of their runs. This behavior is called the
excitatory response. Even though the stimulus might persist, the excitatory
response lasts only seconds before the cell returns to its baseline behavior.
The return to baseline behavior occurs because of the adaptation response.
Both excitation and adaptation occur in response to signals generated by
an inner membrane-bound ternary complex composed of an MCP dimer, a
CheA dimer, and two CheW monomers (Fig 3). This ternary complex relays
information concerning ligand concentration from the outside to the inside of the
cell.

The chemoreceptors: The MCPs are located within the inner
membrane. They are composed of a highly variable periplasmic domain, a
transmembrane region, and a largely conserved cytoplasmic domain. The
degree of conservation among these-different domains speaks to their
respective functions. The periplasmic domains are variable since they bind
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Fig 3. Orcuitry of the chemotactc signal transduction pathway. Chemoreceptors
(MCP) located in the inner membrane transduce signals from the periplagn to OleAL (AL)
or CheAs (As) through the roupling protein CheW ~). CheAautopho~horylates in
response to a decrease in concentration of ligand (Table 1), and, in turn, pho~horylates
the response regulator CheY (Y). Alospho-CheY then interacts with tte flag3llar motor
to change the drection of 10tation from CCW to CW. The phmphatase CheZ (Z)
dephosphorylates CheY. The chemoreceptor adapts to lgand roncentration via receptor
methylation/demethylation. The93 reactions involve the meth~transferase CheR (R)
and the meth~esterase CheB (8).
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different ligands (Table 1). The conservation of the cytoplasmic domain is
necessary because the same internal signal is initiated in response to different
stimuli. In addition, there are two transmembrane regions termed TM1 and TM2
which flank a central, periplasmic ligand binding domain. TM2 is followed by a
linker region which is connected to signaling domain by a short, helical
methylated segment called MH1. The signaling domain is, in turn, followed by
another methylated region called MH2. MH1 and MH2 serve as the
methyl-accepting regions involved in the adaptation response described below.
The cytoplasmic domain is also known as the signalling domain (Ames and
Parkinson, 1994). It is thought that this region transfers the ligand signal from
the periplasmic domain into a coupling protein called CheW which then
transfers this signal into the histidine kinase CheA.
CheW: CheW (14 kDa) couples the signal from the transducer to the

histidine kinase CheA (described in detail below). While the nature of CheW's
MCP-CheA coupling remains elusive, the sites of interaction with CheA and Tsr
have been well characterized (Bourret et al., 1993). Analysis of second-site
repressors of mutations in the chemoreceptor suggest that the signaling region
of the chemoreceptor is the site of interaction with CheW ( Liu and Parkinson,
1991 ).
CheY: Signal transduction through the chemotaxis pathway is

accomplished via the phosphorylation cascade CheA-P + CheY-> CheA +
CheY-P (Fig 4). CheY (14 kDa), the response regulator of the CheA-CheY
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Table 1.--Ligands of the four known methyl-accepting
chemotaxis proteins.
MCP

Attractant/Repellent

Tsr

Serine, Alanine, Glycerol/Leucine

Tar

Aspartate, Glutamate/ Ni2+,Co2+

Tap

Di peptides/Phenol

Trg

Galactose, Glucose

Aer

Oxygen

two-component chemotaxis signal transduction pathway, is a phospho-protein
which, in its phosphorylated form, interacts with the flagellar protein FliM,
eliciting a change in direction of the flagellar motor.

CheZ: CheY is an autophosphatase, with a phospho-aspartate half-life
of only a few seconds. Despite this instability, the rate of spontaneous
dephosphorylation roughly equals that of the rate of phosphorylation. Clearly,
CheY needs a phosphatase to increase the rate of CheY-P degradation. CheZ
(24 kDa) dramatically enhances CheY dephosphorylation. It binds CheY and
presumably forces a conformational change in CheY that facilitates its transition
to a dephosphoryated state (Blat and Eisenbach, 1994; Lukat et al., 1991 ).
The Adaptation Response
The adaptation response functions to maintain the MCPs in a constant
state of readiness so that they may respond to slight alterations in the
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p•~oo+

~

CheV

~

o-o-c=]][[JOO +
Che A

~p•-~

CheY-P*

Fig 4. Transfer of phosphate (P*) from the sensor CheA to the response
regulator CheY. For details concerning the domain organization of CheA,
see Fig 5.

18
concentration of attractant or repellent. For instance, when an E. coli cell is
swimming, the surrounding medium contains fluctuations in the concentration of
attractant. In order to swim in a direction in which life is "better'', E. coli must be
able to sense the presence of a gradiant of the attractant. By fluctuating
between a methylated and unmethylated state, the chemoreceptor "adapts" to
the homogeneity of attractant or repellant in the surrounding medium. In this
way, the chemoreceptor "fine tunes" itself and filters out extraneous noise
caused by homogeneous concentrations of attractant or repellant. The MCP
adapts to attractant or repellant concentration by the action of two proteins, a
methyltransferase (CheR) and a methylesterase (CheB).

CheR: CheR (30kDa) is a methyltransferase which functions in the
chemotactic adaptive response. Its purpose is to methylate glutamate residues
located in the MH1 and MH2 regions of the cytoplasmic side of the
chemoreceptors. CheR accomplishes this by transfer of a methyl group from the
methyl donor AdoMet to the glutamate residues. The degree of strength of
signal through the chemoreceptor correlates with the degree of methylation at
the glutamate residues. Increases in the amount of methylation causes an
increase in rate of CheA autophosphorylation within the ternary complex
(Borczuk et al., 1986; Ninfa et al., 1991). Methylation seems to help regulate the
signaling domain of the chemoreceptor by conformational changes in the
MH1/MH2 regions. The region containing the glutamate residues has been
elegantly shown to be a coiled structure whose torsional state has a
tremendous effect upon the ability of the transducer to transfer a signal to CheA
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(Cochran and Kim, 1996). In other words, as CheR-mediated methylation
proceeds from zero residues to one residue and so on, the magnitude of signal
amplification through the transducer increases.
CheB: CheB (37kDa) is a methylesterase which also functions within

the chemotactic adaptation response. Its purpose is to de-methylate/de-amidate
the glutamate residues and counter methyltransferase-mediated signal
enhancement by CheR. In addition to CheY and the periplasmic domain of Tar,
CheB is the only other chemotaxis protein for which crystallographic data exists.
In addition to CheY, CheB is the only other known protein to be phosphorylated
by CheA. The donation of a phosphate to CheB results in activation of this
protein. An increase in autophosphorylation of CheA leads to an increase in
phosphorylation of CheB and subsequent demethylation of the
chemoreceptors.
Structurally, CheB is a monomer with regulatory and catalytic domains
separated by a linker. The regulatory domain of CheB contains the
phospho-acceptor site and is homologous to the response regulator CheY
(Lupas and Stock, 1989; Stock et al., Cold Spring Harbor Symposium 1988).
Phosphorylation of this domain increases the methylesterase activity of CheB
over 10 fold (Stock et al., 1985). The catalytic domain of CheB has been
revealed to be a wound a/B structure with seven a/B strands (West et al., 1995)
The adaptation response in chemotaxis functions to ''fine tune" the ternary
complex, dampening the effects of extremes of ligand availability. High levels of
methylation activate CheA and low levels inactivate CheA. High levels of
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methylation decrease the affinity of the chemoreceptor for its ligand (Yonekawa
and Hayashi, 1986). So, in low levels of ligand concentration, CheR mediates
methylation of the chemoreceptor which brings about activation of CheA and
decreased affinity for ligand. Activated CheA phosphorylates CheB, which, in
turn, demethylates the chemoreceptor, bringing about an increased affinity for
ligand.

Extreme levels of demethylation causes a decrease in CheA activity,

again decreasing ligand affinity and shutting off the ternary complex. A middle
ground, in which the chemoreceptor is only partially methylated is the ideal
balance sought by the adaptation system. The ternary complex of
CheA/CheW/chemoreceptor exists in a flux between an "on" and an "off'
position. The methylation/demethylation system serves to stabilize the ternary
complex into a state which can respond appropriately to subtle changes in
ligand concentration (Stock and Surrette, 1994).
Functional Organization of CheA
Of the six chemotaxis genes, cheA, the primary focus of this study, is the
most central because it serves as a phospho-donor to both CheY, the excitatory
signal, and CheB, the adaptive signal. The cheA gene encodes two proteins,
CheAL (78 kDa) and CheA8 (69 kDa), translated in-frame from two different
initiation sites (Parkinson and Kofoid, 1992; Smith and Parkinson, 1980) (Fig 5).
Both proteins are histidine kinases of the two-component family (Stock et al.,
1985).
Like other two-component histidine kinases, CheA functions as a dimer
(Gegner and Dahlquist 1991 ). The two-component histidine kinase CheAL
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autophosphorylates a conserved histidine residue (His-48) located near its
amino-terminus (Hess et al., 1988). Phosphorylated-CheAL' in turn, acts as a
phospho-donor for two other chemotaxis proteins: CheY, required for clockwise
signal generation, and CheB, required for adaptation (reviewed in Bourrett et
al., 1991; Stock et al., 1991; Stock and Surette, 1994). CheAL homodimers form
ternary complexes with CheW and chemoreceptors, e.g., Tar (Gegner et al.,
1992). Within these complexes, the autokinase activity of CheAL is
significantly accelerated relative to that of CheAL homodimers alone. Binding of
ligand to the transducer protein, e.g., the Tar-specific attractant L-aspartate,
greatly diminishes CheAL autokinase activity (Borkovich et al., 1989; Borkovich
and Simon 1991; Ninfa et al., 1991 ). Thus, CheW and chemoreceptors
modulate CheAL autokinase activity in a ligand-dependent manner.
Although CheA8 lacks the site of autophosphorylation, it retains domains
that in CheAL are required for kinase activity, ternary complex formation and
phospho-transfer to CheY and CheB (Bourret et al., 1993; Hess et al., 1988;
Kofoid and Parkinson 1988; Morrison and Parkinson 1994; Swanson et al.,
1993). Evidence, obtained in vivo and in vitro, indicates that the CheAL
domains responsible for kinase activity and ternary complex formation also
function in CheA8 . In vitro, CheA8 mediates receptor-modulated
transphosphorylation of mutant CheAL proteins either deficient for kinase
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CheA._ N-

C

Che,¾,

C

Fig 5. The domain organization of the two forms of CheA. Both forms of
CheA are expressed in-frame from alternate translational start sites. P1
contains the site of autophosphorylation (H), P2 is the CheY binding
domain, TL is the site of CheA dimerization, TR contains the putative
catalytic subunits, M and C couple CheA to CheW and chemoreceptor.
The rectangles in TR represent highly conserved sequences.
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activity or truncated for the carboxy-terminal segments required for ternary
complex formation (Swanson et al., 1993; Wolfe et al., 1994; Wolfe and Stewart
1993). In vivo, CheA 8 restores chemotactic ability to cells that express either
kinase-deficient or truncated CheAL mutant proteins (Wolfe et al., 1994; Wolfe
and Stewart 1993).
CheAL and CheA8 are composed of several distinct functional domains
(reviewed in Kofoid and Parkinson 1988; Fig 5). Two of these domains, P1 and
P2, located at the amino-terminus of the protein, are separated by a stretch of
amino acids that resemble charge-rich linkers found in other regulatory and
sensory transduction proteins (Parkinson and Kofoid 1992; Wooten and
Drummond, 1989.). P1 contains the site of autophosphorylation, His-48 (Hess
et al., 1988). This domain, present in CheAL but not in CheA8 , is required for
phospho-transfer to CheY and CheB (Swanson et al., 1993). P2 likely assists in
the interaction between the phospho-donor site in P1 and amino acid
sequences located in CheY (Morrison and Parkinson 1994; Swanson et al.,
1993). Two other domains, M and C, located at the carboxy-terminus, appear to
play important roles in enabling CheAL and/or CheA8 to receive sensory
information from the chemoreceptors (Bourret et al., 1993; Parkinson and
Kofoid, 1992).
Histidine Kinases
Over 100 histidine kinases have been identified to date (Russo and
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Silhavy, 1993; Parkinson and Kofoid, 1992; and Stock et al., 1989). The
histidine kinases are linked into a family by virtue of 5 highly conserved
subdomains termed H, N, G1 (D), F, and G2(G). CheA is atypical of most
histidine kinases in that the H subdomain is located in P1, far removed from the
other conserved subdomains. The N, G1, F, and G2 subdomains, located in the
TR region of the transmitter domain of CheA are characterized by the consensus
sequences illustrated in Fig 6.
The G 1 and G2 subdomains (Fig 6) resemble the glycine-rich regions of
the nucleotide regions of other nucleotide binding domains (Saraste et al.,
1990; Taylor et al., 1992; Schulz 1992; Muller 1993). These subdomains have
previously been proposed to be the site of Mg-ATP binding and catalysis
(Parkinson and Kofoid, 1992). Mutations affecting the ability of CheA to
autophosphorylate have been mapped to this region, suggesting a role for this
region in ATP hydrolysis (Oosawa et al., 1988; Swanson et al., 1994; Wolfe and
Stewart, 1993). The G1 region is of particular interest because the first D and
first G of the DDGAG motif are thought to form a Mg-binding backbone which
would enable proper positioning of of a Mg-ATP complex (Taylor et al., 1992).
To date, no detailed studies have been performed to elicit the
function(s) of the highly conserved residues contained within the putative
catalytic site of CheA. By analysis of mutants defective in selected amino acids
within this region of CheA, this study sought to address the following questions
concerning the function of the conserved subdomains of the CheA transmitter
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C.

s. t.

370
387

E.a.
R.m. 467
R. s. 399
B. s. 399
L. m. 346
H.s. 399
M.x. 367
Consensus
E.c. 411
s.t. 428
E.a.
R.m. 408
R.s. 440
B.s. 440
L.m. 387
H.s. 440
M.x. 408
Consensus

N
iidpLtHlvR NslDHGiElp ekRlaaGKns vgnlilsaeh
iidpLtHlvR NslDHGiEmp ekRleaGKnv vgnlilsaeh

. ......... . . . . . . . . . . . . . . . . . . . . . .........

ladpLtHliR
ladpLtHmiR
igdpLvHliR
igdpLvHliR
isdpLrnHllR
vrdaLvHllR
X-OZL-HXXR
gggnicievt
gggnicievt

. .........
rsqriviela
rsgrvlieik
sgnhvfieve
sgnnvvieia
drdhvligvr
dgdrnlhieve
-Z--X-IOX-

NavDHGlEtp
NavDHGlEpa
NsiDHGlEap
NsvDHGaEtv
NavDHGiEkp
NsvDHGvEsp
NZXDHGXE-Z
Gl
DDGaGlnrer
DDGaGlnrer
•••..... ek
DDGaGinrek
DDGaGinrpr
DDGaGinr.k
DDGaGinkrk
DDGaGidhdt
DDGrGidper
D~ZGXOJOJ

F

E.c.

s.t.

452
469

E.a.
R.m.
R.s.
B.s.
L.m.
H. s.

449
481
481
428
481
M.x. 449
Consensus

ddevarnLiFa
ddevgmLiFa
deevgmliFa
deevdnLiFh
eeeidgLlFrn
dnqiyeLiFa
daeifdLl.d
dddvedLvFh
ereaieLiFr
OOOX--LXF-

pGFSTaeqv
pGFSTaeqv
pGFSTaeqv
aGFSTadki
pGFSTasvv
pGFSTadqi
sGFSTadqv
pGFSTndev
pGFSTrdqv
ZGFSTZOOX

ekRvaaGKnp egtvrltakh
drRlhlGKpp vgliyltaah
etRlgkGKpe sgkvvlkayh
evRrknGKne tatinlkafh
avRednGKDar egtitlsaer
dtRgglGKpl ngririrvrv
O-R---GK-- -z-x-x-z-J

ilak.Aasggl
ilak.Amsggm
ilak.Aaaggl
vrgk.Aidndl
vleiAggkgl
ilekpler.v
vlek.Aiaknv
rnrek.Aiekgv
lrqaAiskrl
XX-JA----X
G2
tdvSGRGVGMD
tdvSGRGVGMD
tdvSGRGVGMD
sdiSGRGVGMD
sdlSGRGVGMD
sdiSGRGVGMD
sdlSGRGVGlD
tdvSGRGVGrnD
selSGRGVGrnD
ZOXSGRGVGXD

. tvse .. nrns
.avne .. nrnt
.avtd .. trns
iaada .. nls
vaqda .. qlt
itekeattle
vtraestkrnt
ktreevqdrnp
inavqaaals
-z--o---xz
WkrniqkrnG
WkrniqernG
WkrniqernG
WkrsiqalG
WksaieslG
WknkleslG
WrntilkiG
Wrdtvtrld
WkrkvetlG
WJ--XO-XG

Fig 6. Amino acid alignment of the N, G1, F, and G2 region of CheA homologs.
Abbreviations are:Eschericia coli (E.c., Kofoid and Parkinson, 1991), Salmonella
typhimurium (S.t., Stock et al., 1988), Enterobacter aerogenes ( E.a., Dahl et al., 1989),
Rhizobium meli/oti (R.m., Greek et al., 1995), Rhodobacter sphaeroides (R.s., Ward et al.,
1995), Bacillus subtilus (B.s., Fuhrer and Ordal, 1991 ), Listeria monocytogenes (L.m.,
Dons, et al., 1994), Halicobacter salinarium (H.s., Rudolph and Oesterhelt, 1995) and
Myxococcus xanthis (M.x., McCleary and Zusman, 1990). Numbers at left respresent
amino acid residues. Strictly conserved residues are capitalized. X refers to residues at
which 70% of the CheA family have a nonpolar amino acid (I,M,L,or V). Z refers to
residues at which at least 70% of the CheA family have a polar amino acid (A,G,P,S, or
T). J refers to residues at which at least 70% of the CheA family have a basic amino acid
(R, K, or H). 0 refers to residues at which at least 70% of the CheA family have an acidic
or amidic amino acid (D,E,Q, or N). Wild-card positions with less than 70% conservation
among the kinase family are indicated with dashes. The N, G1, F, and G2 subdomains
are underlined and strictly conserved residues are in bold.
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N

CheA consensus X-HXXRNZXDHZ
Orthodox kinase X-QXXXNXX-NZ

Gl

F

X-DDGZGXO XF-ZGF
X-DDGZGXZ XFOPF

G2

GJGXGX
GZGXGX

Fig 7. Comparison of the N, G1, F, and G2 consensus sequences between
CheA and orthodox TR domains X refers to residues at which 70% of the CheA
family have a nonpolar amino acid {l,M,L,or V). Z refers to residues at which at
least 70% of the CheA family have a polar amino acid (A,G,P,S, or T). J refers
to residues at which at least 70% of the CheA family have a basic amino acid
(R, K, or H). 0 refers to residues at which at least 70% of the CheA family have
an acidic or amidic amino acid (D,E,Q, or N). Wild-card positions with less than
70% conservation among the kinase family are indicated with dashes. The
strictly conserved residues are in bold.
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domain:
•First, do the subdomains play a role in chemotaxis in vivo?
•Second, do the subdomains play a role in the ability of CheA to
autophosphorylate?
•Third, are the subdomains involved in formation and maintainance of the
ternary complex?
•Fourth, are the subdomains involved in the binding of ATP?
•Fifth, within a CheA dimer, do the conserved subdomains operate
independently and in cis, or interdependently and In trans ?
•Sixth, what can we learn about the structure of the putative catalytic
region of CheA?

CHAPTER3
MATERIALS AND METHODS

Chemicals and Reagents
Bacto-tryptone and bacto-yeast extract were obtained from Difeo (Detroit,
Ml). The restriction enzymes Ndel, BamHI, Munl, Saeli, Xmal, BssHII and M/ul,
the Wizard™ minpreps kit , the Altered Sites TM in vitro Mutagenesis System, and
the Wizard™ M13 DNA Purification System were obtained from Promega
(Madison, WI). BstBI, agarose, glycine, DNA ligase, DNA polymerase, T4
polynucleotide kinase, proteinase K and 5x forward reaction buffer were
obtained from Gibco-BRL (Gaithersburg, MD). RNase-A, alkaline phosphatase
goat anti-rabbit lg, Tris-HCI, isopropyl-B-D-thiogalactopyranoside (IPTG), nitroblue tetrazolium (NBT), Na-ampicillin, tetracycline, chloramphenicol, KCI,
MgCl 2 , dithiothreitol (OTT), ethylenediaminetetracetic acid (EDTA), acrylamide,
and Freund's incomplete adjuvant were obtained from Sigma Chemical
Company (St. Louis, MO). Glacial acetic acid, glycerol, methanol, sodium
dodecyl sulfate (SOS), chloroform, isopropanol, Na2 PO 4 , NaCl, Long Ranger
gel solution {50% acrylamide solution), and dimethyl sulfoxide (DMSO) were
obtained from J. T. Baker Inc. (Phillipsburg, NJ). The bromochloro indolyl
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phosphate (BCIP) bicinchoninic assay (BCA) kit was obtained from Boehringer
Mannheim (Indianapolis, IN).

The lmject Supercarrier™ System for Peptides

was obtained from Pierce Chemicals (Rockford, IL). The Amplicycle™
Sequencing Kit was obtained from Perkin Elmer (Foster City, CA). Biomax
centrifuge filters were obtained from Millipore (Bedford, MA). [y-32 P] ATP and

[a- 32 P] ATP were obtained from Amersham (Arlington Heights, IL).

Bacterial Strains and Alleles
All strains were isogenic derivatives of E. coli K-12 and are listed in Table 2.
Alleles CheA8 (Wolfe and Stewart, 1993), cheA, and cheA48HQ (Oosawa et al.,
1988) encode wild-type CheA 8 alone, both wild-type CheA 8 and wild-type
CheAL, and both wild-type CheA8 and the mutant protein CheAL48HQ,
respectively. This mutant protein cannot autophosphorylate because of a
His-Gin substitution at position 48. Alleles cheA422GA (herein called cheAG1),
cheA470GA472GA474GA (cheAG2), cheA422GA470GA472GA4 74GA
(cheAG 1/G2) and cheA455FY459FY ( cheA2FY) encode CheA 8 and CheAL

proteins disrupted in G 1 alone, G2 alone, both G 1 and G2 or F alone,
respectively. Each mutation and unique restriction sites used to track these
mutations during various in vitro manipulations were generated using standard
oligonucleotide-directed mutagenesis procedures (Kunkel, 1985).
Oligonucleotides used for mutagenesis are illustrated in Table 3 and the

30
Table 2. --Bacterial strains used in this study
Strain

Relevant Genotype

Source

AJW531

RP437 cheA470GA472GA474GA recA::cml eda:+-

This
Study

AJW953

RP437 cheA422GA470GA472GA474GA
sr/::Tn 10 eda+

This
Study

AJW955

RP437 cheA 422GA recA sr/::Tn 10 eda+

This
Study

AJW1071

RP9535 recA::cml

This

BL21(DE3)

F- ompT hsdSs (rs- ms-) Ion dcm (').Jmm21 lacl

Studier et
al. (1990)

/acUV
T7 polymerase int)

BMH71-18
mutS

thi supE A(lac-proAB) mutS::Tn 10/F' proA+ £3+
lac/OZ AM 15

Kunkel
(1985)

CP366

po/A(Ts)

Park and
Hazelbau
er(1986)

DH5cx

endA 1 hsdR17 (rK-mK-) supE44 thi-1 recA 1 gyrA

Woodcock et
al.(1989)

(NalR) re/A 1 A(lac/ZYA-argF)U169 deoR
(<P80d/ac A(/acZ)M15)

JM109

F' traD36 /acP A(lacZ)M15 proA+£3+ I e14- (McrA) YannischA(/ac-proAB) thi gyrA96 (NalR) endA 1 hsdR17
(rK-mK-) re/A 1 supE44 recA 1

Perron et
al. (1985)

KO685

ArecA (Sstll-EcoRI) sr/::Tn 10

Hess et
al. (1987)

MH6

recA::cml

A. Binney
a

RP437

RP9535

thr(Am) 1 /eu86 his-4 metF(Am) 159 eda-50
rpsL 136 thi-1/acY1 ara-14 mtl-1 xy/-5 tonA31
tsx-78

RP437 AcheA 1643 recA:: cm/ eda+
a A. Binney, Purdue University, West Lafayette, Indiana

Parkinson
and Houts
(1982)
Liu (1990)
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Table 3.--Mutagenesis and sequencing primers
Primer#

M/S 8

Allele

Sequence

1

M

G1

5'-ACCGACGATGCCGCGGGGCTAA-3'

2

M

G2

5'-GACGTCTCCGCGCGCGCCGTCGCCATGGACGTC-3'

3

M

F

5'-ATGCTGATATACGCACCCGGGTACCCACGGCAG-3'

4

M

CheA709

5'-CCACCCCACATATGCTTAAAC-3'

5

s
s
s
s

CheA

5'-AGAACGCATTATCGACCCGC-3'

CheA

5'-ATTCCATAACAGCATTCAGCG-3'

T7

5'-AACAGCTATGACCATG-3'

CheA

5'-CCTGGCTTCTCCACGGCAGAGC-3'

6

7
8

a: M refers to mutagenesis primers and S refers to sequencing primers

alleles presented in Fig 8. The following oligonucleotides were used: (i) to
generate the allele cheAG1, 5'-ACCGACGATGCCGCGGGGCTAA-3' which
substitutes an alanine residue for a glycine at position 422 (Fig 6 and 8) and
which introduces a unique Saeli restriction site into G1; (ii) to generate the allele
cheAG2, 5'-GACGTCTCC GCGCGTCGCCATGGACGTC-3' which substitutes

alanine residues for glycines at positions 470, 472, and 474 (Fig 6 and 8) and
which introduces a unique BssHII restriction site into G2; and (iii) to generate
the allele cheA2FY 5'-ATGCTGATATACG CACC CGGGTACCCACGGCAG-3'
which substitutes tyrosine residues for phenylalanines at positions 455 and 459
(Fig 6 and 8) and introduces a unique Xmal restriction site in F. Allele
cheA.1(468-477) (herein called cheA~G2) encodes CheA and CheAL proteins
8
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Allele

-G1

F

--G2

WT
cheA- G1

DDGAG

FAPGF

GRGVG

DDAAG

FAPGF

GRGVG

cheA-G2
cheA- G1/G2
cheA-t:,G2
cheA-2FY

DDGAG

FAPGF

;RAVA

DDAAG

FAPGF

/P.AVA

DDGAG

FAPGF

6

DDGAG

YAPGY

GRGVG

Fig 8. Functional organization of CheA and schematic of cheA
alleles used in this study. The shaded bars within TR represent the
N, G1, F, and G2 blocks of highly conserved amino acids shared by histidine
kinases of the family of two-component signal transduction systems. Mutant
amino acids are italicized and underlined.
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deleted for nine amino acids including those that comprise the entire G2 region
(Fig 6 and 8).
Media and Growth Conditions
Cells were grown with aeration in tryptone broth (TB, 1% (wt/vol)
Bacto-tryptone, 0.5% (wt/vol) sodium chloride) or in Luria-Bertani broth (LB, TB
supplemented with 0.5% (wt/vol) Bacto-yeast extract). The optical density at
61 O nm (OD 610 ) was monitored (Spectronic 20D, Milton Roy Company).
Bacteria strains containing plasmids to be made single-stranded for
site-directed mutagenesis were prepared for R408 phage lysis by growth in TYP
broth (1.6%(wt/vol) Bacto-tryptone, 1.6% (wt/vol) Bacto-yeast extract,
0.5%(wt/vol) NaCl and 0.25% (wt/vol) K2 HPO4 ). Competent cells were
prepared in Yb medium (2% Bacto-tryptone, 0.5% Bacto-yeast extract, and
0.5% MgSO4 , pH 7.6).
Swarm Assays
Cells were grown at 32°C to mid-exponential phase (OD 610 ~ 0.3) in TB
supplemented with the requisite antibiotics. Tryptone swarm plates (100 x 15
mm, Falcon) were constructed by adding 15 ml of 0.20% agar in tryptone broth.
Antibiotics were not added. A 5 µI aliquot of the culture (106-10 7 cells) was
placed on the surface of the swarm plate near its center and the plate incubated
at 32°C in a humid environment. Swarm plates were handled and measured as
described previously (Wolfe and Berg, 1989).
Plasmids used for in vivo swarm plate analyses were derivatives of pAR1
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(Gegner and Dahlquist, 1991 ), which controlled the expression of the cheA
alleles.
Plasmid Construction
All expression plasmids used to purify proteins were constructed using the
pET14b (Novagen) his tag purification vector and for the purpose of clarity were
designated as pDE followed by the allele name Table 4. All expression
plasmids used for behavioral studies are based on the pAR1 vector (Gegner
and Dahlquist, 1991) and are designated as pAR1 followed by the allele name
(Table 4).
To construct the CheAL purification plasmid pDE.cheA, the CheA
expression plasmid pAR1 .cheA (Wolfe and Stewart, 1993) was digested with
Ndel and BamHI. The 2.1-kb fragment containing the cheA gene was ligated

into an Ndel - BamHI digest of pET14b. To form the CheA8 purification plasmid
pDE.CheA 8 , the CheA8 expression plasmid pAR1 .CheA8 (Wolfe and Stewart,
1993) was digested with Ndel and BamHI. The 1.8-kb fragment containing the
CheA8 gene was ligated into an Ndel - BamHI digest of pET14b. The mutant
allele CheMG2 was generated by digestion of pAR1 .cheA with Aatll. The 27
bp Aatll-Aatll fragment was discarded and the remainder of the plasmid ligated
to create an in-frame deletion of 9 amino acids encompassing the G2 region.
The resulting CheA~G2 expression plasmid was named pAR1 .cheA~G2. To
construct the purification plasmid pDE.cheA~G2, pAR1 .cheAL1G2 was digested
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with Ndel and BamHI and the 2.09-kb fragment ligated into a pET14b plasmid
which had also been digested with Ndel and BamHI. pDE.cheA48HQ a
purification plasmid, encoding the phosphorylation-deficient CheAL48HQ, was
generated by removal of a 1.43-kb Munl - Mlul fragment from the CheAL48HQ
expression plasmid pCS30. This fragment was ligated into a 5.22-kb fragment
of a Munl - Mlul digest of pDE.cheA. pAR1 .cheA48HQ, a cheA48HQ expression
plasmid, was constructed by removal of a 2.1 kb Ndel - BamHI fragment from
pDE.cheA48HQ, removing the entire cheA48HQ allele. This fragment was
ligated into a pAR1 vector derived by digestion of pAR1 .CheA8 with Ndel and
BamHI. To construct the purification plasmid pDE.cheAG1, a 2.1 kb Ndel -

BamHI digest of the expression plasmid pJN.cheAG1(pJN19) was ligated into
an Ndel - BamHI digest of pET14b. To construct the expression plasmid
pJN.cheAG1, a 2.1-kb Ndel - BamHI digest of pJN001.cheAG1 (a pAlter™

plasmid containing cheAG1) was ligated into a vector resulting from an Ndel
-BamHI digest of pAR1 .cheA . To construct pAR1 .cheAG2, a 692 bp BstE II BamHI of pDE.cheAG1/G2 was ligated into a vector resulting from a BstBIBamHI digest of pAR1.cheA. To construct pDE.cheAG2, a 2.1-kb Ndel-BamHI
digest of pAR1 .cheAG2 was ligated into an Ndel - BamHI digest of pET14b.
The expression plasmid pDE.cheAG1/G2, was constructed by removal of a
2.1-kb Ndel -BamHI fragment of pJN001.cheAG1/G2 (a pAlter based plasmid
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Table 4.--Plasmids used in this study
Expression
Aasmids

Plasmids to Express
his-tagged Proteins

cheA(WT)

pAR1.cheA

pDE.cheA

cheA~WT)

pAR1.cheAs

pDE.cheAs

cha4422GA

pAR1 .cheAG 1

pDE.cheAG1

cheA470GA/472GN47 4GA

pAR1 .cheAG2

pDE.cheAG2

c~A422 GA/ 470GA/472GA/ifl4GA

pAR1 .cheAG1/G2

pDE.cheAG1iG2

cha4481-0

pAR1 .cheA4BHQ

pDE.cheA48HQ

cheAA(468-476)

pAR1 .cheAAG2

pDE.cheAAG2

Mutation and/a r Allele

containing the cheAG1/G2 mutation). This fragment was ligated into a vector
resulting from an Ndel - BamHI digest of pAR1 .cheA. To construct
pDE.cheAG1/G2, a 2.1-kb Ndel-BamHI digest of pJN.cheAG1/G2 was ligated
into an Ndel-BamHI digest of pET14b. To construct pAR1 .cheAG2, a 692 bp
BstEII-BamHI digest of pDE.cheAG1/G2 was ligated into a vector resulting
from a BstEII-BamHI digest of pAR1 .cheA. This fragment was ligated into
a vector resulting from an Ndel - BamHI digest of pAR1 .cheA. To construct
pDE1.cheAG1/G2, a 2.1-kb Ndel - BamHI digest of pJN.cheAG1/G2 was ligated
into an Ndel - BamHI digest of pET14b. To construct pAR1 .cheAG2, a 692 bp
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BstBI - BamHI digest of pDE.cheAG1/G2 was ligated into a vector resulting from

a BstE II - BamH I digest of pAR1 .cheA.
Competence Procedure
To make cells competent for transformation, a single freshly isolated colony
was inoculated into 125 mis of Yb medium and aerated at 37°C until the culture
reached an optical density (OD 550) of 0.3. This culture was diluted 1:20 in
pre-warmed Yb medium and grown at 37°C with aeration until the culture
reached an OD 550 of 0.48, whereupon it was immediately placed on ice for 5
min and then pelleted by centrifugation at 3000 x g in a Beckman tabletop The
cell pellet was resuspended in 40 mis cold (4°C) Tbf1 buffer (30 mM KOAc (pH
5.8), 100 mM KCI, 10 mM CaCl 2 , 50 mM MnCl 2 , 15% glycerol) for 5 min and
pelleted by centrifugation at 3000 x g. The supernatant was decanted and the
pellet resuspended in 4 mis of Tbf2 (1 O mM MOPS (pH 6.5), 75 mM CaCl 2 , 1O
mM KCI, 15% glycerol) and left at 4°C for 15 min before use. Cells were divided
into 250 µI aliquots and stored frozen at -70°C until needed (approx. 0.5 x 109
cells/ml).
Site-Directed Mutagenesis
Mutagenesis of the putative catalytic domain was performed using the
Altered Sites™ in vitro Mutagenesis System (Promega). A BamHI digest of
pAR1 .cheA which included both cheA and flanking sequences was ligated into
a calf alkaline phosphatase (CIP, Gibco-BRL)-treated BamHI digest of the
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mutagenesis vector pAlter™. The ligation reaction was transformed into DH5a,
plated onto LB plates containing tetracycline (15 µg/ml), and incubated at 37°C
for 16 hrs. Tetracycline resistant colonies were inoculated into 5 mis of LB
containing tetracycline (15 µg/ml) and allowed to grow to saturation overnight at
37°C. The overnight cultures were pelleted by centrifugation and the plasmids
isolated by use of the Wizard™ miniprep DNA purification system. The insert
was mapped by restriction analysis for a 5' - 3' orientation relative to the T7
promotor present in pAlter™. A plasmid containing the proper insert in the
correct orientation was selected and named pJN001.
Single-stranded DNA used as a template in all site-directed mutageneses
was obtained by transforming pJN001 into strain JM109. One freshly isolated
colony was inoculated into 2 mis of TYP broth and incubated overnight at 37°C
with aeration. 100 µI of the overnight culture was inoculated into 5 mis of TYP
broth containing 15 µg/ml of tetracycline and aerated at 37°C. After 30 min, the
culture was infected with the helper phage R408 at a multiplicity of infection
(MOI) of approximately 10, shaken for an additional 6 hrs, and the culture was
then centrifuged at 3000 x g to remove whole cells and debris. Single-stranded
DNA was isolated from the supernatant by use of the Wizard™ M13 DNA
purification system.
Mutagenesis of pJN001 was performed according to the guidelines
outlined by Promega . Phosphorylated oligonucleotides (one designed to
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introduce a mutation into CheA and one designed to repair the ~-lactamase
gene in pAlter) were annealed to the single-stranded pJN001 template (0.05
pmol pJN001, 0.25 pmol ampicillin repair oligonucleotide, 1.25 pmol cheA
mutagenic oligonucleotide, 2 µI 1OX annealing buffer, final volume 20 µI) by
incubation at 70°C for 5 min and slow cooling to room temperature for 30 min.
The annealing mix was allowed to extend and repair (3 µI 1OX synthesis buffer,
1O U T4 DNA polymerase, 2 U T4 DNA ligase, final volume 30 µI) at 37°C for 90
min. Following the extension reaction, the entire mix was transformed into
competent BMH71-18 mutS cells. The BMH71-18 mutS containing the
mutagenesis mix was inoculated into 4 mis of LB containing 100 µg/ml of
ampicillin and incubated overnight at 37°C with aeration. The overnight culture
was pelleted by centrifugation at 3000 x g and plasmids isolated by the
miniprep system described previously. The plasmid preparation then was
transformed into competent DH5a cells and plated on LB agar containing
ampicillin (100 µg/ml) and tetracycline (15 µg/ml). Ampicillin resistant colonies
were inoculated into 5 mis of LB broth containing ampicillin (100 µg/ml) and
grown overnight at 37°C with aeration. Plasmids isolated from these overnight
cultures were mapped for the presence of the unique restriction sites introduced
as markers for each mutation. All mutations generated were confirmed by
sequence analysis.
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Homologous Recombination
Alleles cheAG1, cheAG2 and cheAG1/G2 were introduced into the
chromosome by means of homologous recombination in the po/A {Ts) strain
CP366 (Park and Hazelbauer, 1986). Briefly, plasmids containing the mutant
alleles were transformed into CP366, plated onto LB plates supplemented with
ampicillin (100 µg/ml), and incubated overnight at 42°C. Ampicillin-resistant cointegrants were selected, inoculated into LB without antibiotics and passaged
repeatedly (1 0 X) at 37°C. A sample of the final passaged culture was serially
diluted such that about 200 colonies were plated onto LB plates without
antibiotic and grown overnight at 37°C. Ampicillin-sensitive recombinants were
identified by replica-plating onto LB plates either containing ampicillin (100
µg/ml) or not. Chromosomal preparations were prepared from 6 ampicillinsensitive colonies and the existence of each mutation verified by restriction
analysis of polymerase chain reaction (PCR) products using primers designed
to amplify the entire G1-F-G2 region. Each mutation was marked by a silent
mutation that introduced a unique restriction site that flanked the mutation.
P1 transduction (Silhavy et al., 1984) was used to transfer each mutant
allele out of its PolA(Ts) host into the PolA+RecA+Che+ recipient strain RP437
and to make the resultant transductants recA by using either strain MHS- or
KO685 as the donor. The recipient strain RP437 carries an eda- phenotype.
Recombinants of the chemotaxis operon (42.5 min) of RP437 can be selected
by virtue of repair of the eda locus (41.5 min). Transductants that recombined
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the mutated cheA alleles into RP437 were selected by their eda+ phenotype.
The eda+ recombinants were screened for nonchemotactic behavior. Those
that proved nonchemotactic were then tested for their ability to perform wild-type
chemotactic behavior when transformed (Silhavy et al., 1984) with pAR1 .cheA,
a plasmid that encodes both CheA8 and CheAL. Chromosomal preparations
were prepared of each putative recombinant and the entire G 1-F-G2 region
amplified by PCR. The presence of the mutation was verified by restriction
analysis and sequencing of the amplified product. The mutant alleles are
presented in Fig 8.
Purification of His-tagged proteins
To purify CheAL, the 2.1-kb Ndel-BamHI fragment from pAR1 .cheA
(Wolfe et al., 1994) was subcloned into pET14b (Novagen Inc., Madison, WI),
generating the plasmid pDE1. This plasmid permits expression, by means of
the bacteriophage T7<!>1 O promoter, of a 6XHis sequence fused to the
amino-terminus of CheAL. To purify mutant CheAL proteins, the 5.9-kb Stul-M/ul
restriction fragment of pDE1 was ligated to 1.2-kb Stul-Mlul fragments from each
of the respective pAR1 derivatives. To purify CheA8 , the 1.8-kb Ndel-BamHI
fragment from pAR 1.CheA8 (Wolfe et al., 1994) was subcloned into pET14b
(Novagen Inc., Madison, WI). To purify the TMC fragment of wild-type CheA, an
Ndel site was engineered at cheA nucleotides 706 - 711 and the resultant

1.4-kb Ndel-BamHI fragment was subcloned into pET14b. Each protein used in
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this study was purified by transforming the plasmid which expressed the
appropriate 6X his-CheA variant fusion protein under control of the T7 promoter,
into BL21 (DE3), a strain which expresses T7 RNA polymerase under the control
of lacP {Studier et al., 1991 ). Cells of the resultant transformant were grown
overnight in 5 ml of LB in the presence of ampicillin (100 mg/ml). The overnight
culture was diluted 1: 100 in LB containing ampicillin (200 mg/ml) and grown to
an OD 610 of~ 0.4 at 30°C before adding 0.1 mM IPTG and more ampicillin (200
µg/ml). After a 3 hr incubation under inducing conditions, the cells were
harvested by centrifugation at 3,000 x g for 20 min at 4°C. Purification of the
fusion protein and cleavage of the 6XHis sequence were performed according
to the manufacturer's instructions (Novagen [Hoffman and Roeder, 1991 ]),
except that the thrombin:protein ratio was 1: 1000. Protein concentrations were
determined by the BCA assay.
To purify the 30-kDa fragment that results from spontaneous
degradation of the mutant protein CheALG 1, we filtered the mixed degradative
pool of that protein through a SOK nominal molecular weight limit (NMWL)
Biomax filter (Millipore). Because the protein was fused to an amino-terminal
6X his sequence, we reabsorbed the resultant Biomax filtrate over His-bind
resin (Novagen), eluted those fragments that bound, and equilibrated them in
TKMD buffer (50 mM Tris-HCI, 50 mM KCI, 5 mM MgC1 2 , 0.5 mM dithiothreitol
[pH 7.51).
To purify spontaneous degradative fragments of CheAL G1 that include the
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TMC domains, we first absorbed a mixed degradative pool of CheAL G 1
fragments to His-bind resin to remove any fragments containing an
amino-terminal 6XHis sequence. We then filtered the unbound fragments
sequentially through SOK NMWL and 30K NMWL filters. This process resulted
in a mixed population of fragments ranging in size from 30- to 50-kOa,size
range which includes TMC-containing fragments.

In Vitro Phosphorylation of Proteins. SOS-PAGE. Autoradiography and
lmmunoblot Analysis
Phosphorylation reactions contained the indicated proteins in TKMO buffer
and 50 µM [y-32 P]ATP (~ 2500 cpm pmol" 1) at 25°C for the times indicated.
Reactions were terminated by the addition of 3X SOS-PAGE sample buffer.
Samples were subjected to SOS-PAGE (10% polyacrylamide gels) at 10 to
15°C in a Hoefer (San Francisco, Ca) SE600 gel apparatus under the
conditions of Laemmli (1971 ). Following electrophoresis, the gels were
incubated for 2X at 25°C for 1 hr in drying buffer (45% methanol, 7.0% glacial
acetic acid, 10% glycerol, 0.5% dimethyl sulfoxide), dried for 2 hrs and
visualized by autoradiography.
Sequencing
Mutations in the catalytic domain were confirmed by direct cycle
sequencing using the Amplicycle sequencing kit (Perkin-Elmer). Templates for
sequencing were derived either from plasmids containing mutant alleles in the
catalytic domain of cheA or chromosome preparations from E. coli cells which
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had cheA catalytic site mutations introduced into the chromosome by
homologous recombination. For each allele sequenced, 6 µI of the template
mix (4 µI of cycling mix, 1 µI of [y2P]-ATP, 15 µI of template (100-150 µg/ml), and
1O µI of sterile H 0 ) was added to 0.25 ml microfuge tubes containing 2 µI each
2

of the G, A, T, and C termination nucleotides. 7-deaza-GTP was added to inhibit
compressions.
The sequencing mix was subjected to 30 cycles in an an Omn-E,
(Hybaid) thermocycler under the following conditions. Pre-warm cycle (5 min,
95°C), melting cycle (1 min, 95°C), annealing cycle (1 min, 62°C), extension
cycle (1 min, 72°C).
Primer End-Labeling
Primers used for sequencing were end-labeled according to the method
of Donis-Keller et al. (1977). A reaction mix was prepared consisting of 5 pmol
primer, 5 µI of 5X forward reaction buffer, 1 µI (10 U) of T4 polynucleotide
32

kinase, 2.5 µI of [ y- P]ATP (10 µCi/ul, 3000 Ci/mmol), and sterile H 0 to a total
2

volume of 25 µI. The contents were mixed thoroughly and incubated at 37°C for
10 min. The reaction was stopped by the addition of 4 µI of 500 mM EDTA.
Alternatively, a reaction mix was prepared consisting of 5 µI [y-32 P]ATP
(10 µCi/ul, 3000Ci/mmol), 1 µI of 10x reaction buffer, 1 µI of 100 mM DTT, 3 µI of
T4 polynucleotide kinase and 0.8 µI of 20 µM primer. The contents were mixed
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thoroughly and incubated at 37°C for 10 min. The reaction was terminated by
incubation of the mixture at 94°C for 5 min.
Genomic DNA Preparation
To confirm chromosomal mutations in the putative catalytic domain of
CheA, genomic DNA was prepared as described (Ellefson and Wolfe 1997).
100 mis of E. coli cells were grown overnight in LB. The overnight culture was
pelleted by centrifugation and washed once in 1X SET buffer (20 mM Tris pH
7.5, 75 mM NaCl, 25 mM EDTA). The washed pellet was resuspended in 5 ml
of SET buffer and transfered to a 15 ml polypropylene tube. Lysozyme was
added to 1 mg/ml and the solution incubated at 37°C for 30 min. RNase A was
added to a concentration of 0.4 mg/ml and the solution incubated for an
additional 30 min at 37°C.

Following the 60 minute incubation, 0.1 volumes of

10% SOS and 1 mg/ml of proteinase K was added and the entire solution
mixed and allowed to incubate in a 56°C water bath. After 2 hrs, 0.33 volumes
of 6M NaCl was added to the solution and mixed gently. One volume of
chloroform was then added and the entire solution rotated for 1 hr at 23°C. The
solution was then centrifuged for 1O min at 3000 X g to separate the organic
phase from the aqueous phase. The aqueous phase was transferred to a fresh
15 ml polypropylene tube. One volume of isopropanol was added and the
solution was inverted frequently to precipitate the chromosomal DNA. The DNA
was transferred with a glass pipet to a 1.5 ml microfuge tube, rinsed with 70%
EtOH, and pelleted by centrifugation. The supernatant was decanted from the
pellet which was air dried to remove extraneous EtOH. The dried pellet was
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resuspended in cold H2 0 and stored at -20°C.
Western Analysis
lmmunoblot analyses, using affinity-purified rabbit anti-CheA antibodies,
were performed by standard procedures (Harlow and Lane, 1988). 40 µg or 5
µg of a total protein lysate were separated by SOS-PAGE analysis. The
proteins were transferred to nitrocellulose (0.2 µm, Schleicher and Schull) in a
Trans-Blot cell (Bio-Rad, Hercules) overnight at 4°C and 40V. The transfer
buffer contained the following: Tris 3 g/I, Glycine 14.4 g/1, Methanol 200 ml/I.
Unreacted sites on the nitocellulose blot were blocked by immersion for 1 hr in
100 mis of blotto (Tris-buffered saline/ 0.1% Tween-20 (TBS-T), 5% nonfat dry
milk). The blots were rinsed twice and then washed three times each for 15
min in TBS-T on a rotating platform. Pre-absorbed anti-CheA antiserum or
anti-CheAL serum were diluted to a concentration of 1 : 10,000 in TBS-T and
incubated with the appropriate blot for 1 hr at room temperature. Following
incubation with primary antibody, the blots were rinsed and washed as
described above. The blots were incubated for 1 hr at 23°C with
alkaline-phosphatase conjugated anti-rabbit lgG (Sigma) diluted in TBS-T to a
concentration of 1 : 15,000. The blots were washed with TBS-T once for 15
min and three times for 5 min to remove unbound antibody. Following the
wash, the blots were rinsed twice with an equilibrating buffer consisting of 150
mM NaCl, 50 mM Tris-HCI, [pH 7.5]. Reactive bands were visualized by adding
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66 ml of nitro blue tetrazolium (NBT, 50 mg/ml in 70% dimethylformamide,
Sigma) and 33 ml of bromochloro indolyl phosphate (BCIP, 50 mg/ml in 100%
dimethylformamide, Sigma) into 1O ml of alkaline phosphatase buffer (100 mM
Tris-HCI pH9.5, 5 mM MgCl 2) and incubating the blot until color development
occurs. The reaction was stopped by the addition of 5 mM EDTA. Blots were
washed in distilled H2 0 and dried between Whatman filters.
Generation of CheAL-Specific and CheA antisera
High-titer antiserum recognizing only the long form of CheA was
generated in rabbits by immunization with a conjugate of a CheAL-specific
peptide and bovine serum albumin (BSA) carrier. A CheAL-specific peptide,
IKGGAGTFGFS, corresponding to amino acids 50-60 in CheAL was coupled to
BSA and keyhole limpet hemocyanin (KLH) by use of the lmject Supercarrier™
EDC system for Peptides (Pierce). The peptide/KLH conjugate was used as an
irrelevant carrier to screen the resulting antiserum for peptide reactive antibody
by ELISA. Each carrier was reconstituted into 200 µI of deionized water and
incubated with 2 mg of peptide dissolved into 500 µI of conjugation buffer (pH
4.7). The peptide/carrier mix was added to a vial containing
1-ethyl-3-(3-dimethylaminopropyl carbodiimide) hydrochloride (EDC). The
peptide/carrier/EDC mix was allowed to incubate at 23°C for 2 hrs. The
peptide/carrier conjugates were purified over a cross-linked dextran sulfate
column pre-equilibrated with purification buffer (83 mM Na2 PO 4
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pH 7.2, 900 mM NaCl). 0.5 ml aliquots of purification buffer were absorbed over
the column and collected in separate tubes for analysis. The hapten-carrier
conjugate, eluted in fractions 4 - 6. These fractions were pooled and the
coupling efficiency calculated by comparing of peptide (by absorbance at
280nm) before conjugation with the peptide concentration in the eluate arising
from the coupling column. The coupling efficiency of the peptide to both the
BSA and KLH carrier conjugates was estimated at approximately 78% (approx.
10 peptides/molecule BSA). The BSA/peptide conjugate was dialyzed against
phosphate buffered saline (PBS), quantitated by BCA analysis (a protein
determination kit from Pierce), and 100 µg resuspended in 1 ml of Fruend's
incomplete adjuvant. The mixture was shaken for 1 min in a model 5100
mixer/shaker (Spex) and drawn into a 3 ml disposable syringe. Pre-immune
serum was collected from a female New Zealand White rabbit (approx. 5 kg).
The rabbit was injected subcutaneously at 5 separate sites in the dorsal-lumbar
region. After 4 weeks, the rabbit was boosted with 50 µg of the peptide/ BSA
conjugate in a manner similar to that outlined above. Two weeks after
boosting, 35 mis of blood was taken by ear puncture and the serum collected by
allowing the blood to coagulate overnight at 4°C. Serum reactivity against the
peptide was analyzed by indirect detection of peptide titer by enzyme-linked
immunosorbant assay (ELISA) using the peptide-KLH conjugate as the antigen
according to the method of Van Regenmortel (1988) . Briefly, 50 µg/ml of
peptide/KLH conjugate was dialyzed against carbonate buffer (15mM Na2CO3 ,
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35 mM NaHCO

3

,

pH 9.6, 4°C). Each well of a a 96-well plate was absorbed

overnight at 4°C with 100 µI of the dialyzed peptide/KLH conjugate mixture.
The plates were washed three times with PBS/0.1 % tween-20 and the
unreacted sites blocked by incubating the plate at 37°C for 1 hr with a 100 µI of
10 mg/ml of KLH in PBS/0.1 % tween-20. The unreacted KLH was removed by
washing 3 times in PBS/0.1 % tween-20. Peptide-reactive antiserum was
quantitated by aliquoting 100 µI/well of 2-fold serial dilutions of serum ranging
from 1:100 to 1:10,000 and incubating the plate at 37°C for 2 hr. The plate was
washed 3 times in PBS/tween-20 and incubated with alkaline-phosphatase
conjugated goat anti-rabbit lg (Sigma, 1:10,000) for 2 hrs at 37°C. The wells
were washed 3 times with PBS/tween-20 and incubated for 2 hr at 37°C in
substrate (3 mM p-nitrophenyl phosphate, 0.05 M Na CO
2

3

,

0.5 mM MgCl

2

).

The absorbance was read at 405 nm with a spectrophotometer.
Generation of antiserum against both the long and short forms of CheA
was performed in a manner similar to the one outlined above except his-tagged
CheA protein was used as the primary immunogen instead of a
peptide-conjugate mixture.
ATP Binding Assay
The binding of ATP to wild-type and mutant CheA was performed
according to the method of Ninfa et. al (1993). Each wild-type and mutant CheA
protein was diluted to 5 µM in TKMG buffer (50 mM Tris-HCI pH 8.0, 60 mM
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KCI, 5.0 mM MgCl

2

,

and 5.0% glycerol), and incubated with [a- 32 P]ATP. A 40

µI aliquot of each protein was dispensed into separate wells of a 96 well
microtiter plate and exposed to UV light (254 nm) for 3 min with a UV
Stratalinker model 1800 (Stratagene, LaJolla, California).

The reactions were

stopped by the addition of 3X sample buffer and subjected to SOS-PAGE and
autoradiography.
Quantitation of ADP binding was performed as described (Thomas et al.
1992; Hiratsuka 1982). Progressively higher concentrations of the fluorescent
ADP analog TNP-ADP were titrated into a 1O µM concentration of wild-type or
mutant CheA. By itself, TNP-ADP has a low level of fluorescence, but there is a
significant increase in fluorescence when the analog is bound to a kinase. This
increase was quantified by measurement of the absorption spectra in an
Applied Photophysics SX19MV spectrofluorimeter (model SK.1 E). Data were
plotted as fluorescent intensity versus TNP-ADP concentration. These titration
profiles were fitted with a least squares program to calculate the binding affinity
of the analog.

CHAPTER4
RESULTS

In Vivo Analysis of CheA Putative catalytic domain Mutants

Rationale for design of catalytic mutants: Parkinson and Kofoid
(1992) proposed, on the basis of sequence homology to the catalytic sites of
eukaryotic serine/threonine kinases, that the transmitter domain of CheA is the
site of ATP catalysis. To test this hypothesis, ideally one would first derive
structural information from x-ray crystallography or multidimensional NMR
analyses and then obtain information via functional analysis of selected
mutants. Unfortunately, there have been no successful structural studies of the
putative catalytic domain of CheA or that of any other two-component histidine
kinase.

Thus, I have chosen to use mutagenesis to obtain functional and

structural information concerning the putative catalytic domain of CheA. To
design a mutagenic strategy, I first compared the sequence of the catalytic
domains of serine/threonine kinases and with that of several histidine kinases
(Saraste et al. 1990, Schultz 1992, Taylor et al. 1992, Ninfa et al. 1993, Yang
and Inouye 1993). I chose three highly conserved regions (G1, F, and G2) for
51
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mutant analysis of catalytic function. Since G 1 and G2 are glycine-rich regions,
I decided to generate a series of conservative glycine to alanine changes
because researchers have traditionally used alanine substitutions to facilitate
functional analysis of the catalytic regions of other kinases (Atkinson and Ninfa;
1993, Ninfa et al., 1993) and because a variety of structure averaging
algorithms predicted that G to A substitutions would cause no obvious
alterations in the secondary structure of those regions. Thus, I expected that
such mutations had a good chance of preserving the general architecture of the
mutated protein. In the F region, which is phenylalanine-rich, I introduced F to
Y and F to W mutations. Because tyrosine (Y) differs from phenylalanine (F)
only in the presence of a reactive hydroxyl group on the aromatic ring, I
expected F to Y to be the most conservative of the two substitutions. In contrast,
I expected that a tryptophan (W) substitution might cause a more severe
phenotype since it contains an additional ring that may cause steric problems
(Sharp et al. 1995, Sharp, et al., 1995).
Using these mutations, I sought to address the following questions
concerning the function of the conserved subdomains within the transmitter
domain of CheA:
•First, do these subdomains play a role in chemotaxis in vivo?
•Second, do these subdomains play a role in the ability of CheA to
autophosphorylate?
•Third, are the subdomains involved in formation and maintainance of the
ternary complex?
•Fourth, are the subdomains involved in the binding of ATP?
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• Fifth, within a CheA dimer, do the conserved subdomains operate
independently and in cis, or interdependently and in trans ?
•Sixth, can we make predictions concerning the structure of the putative
catalytic region of CheA?
Mutant Alleles Defective in the Putative Catalytic Domain do not Support
Chemotaxis/n Vivo
A deletion of cheA eliminates the ability of the cell to perform chemotaxis
(Liu and Parkinson, 1989). Since CheA is a histidine kinase, mutations
designed to disrupt the binding of ATP should affect the ability of CheA to
autophosphorylate. Such mutations would disrupt the phospho-relay and, thus,
affect chemotaxis. Thus, I inoculated cells carrying either the wild-type allele
cheA (strain RP437) or the mutant allele cheAG1 (strain AJW955), cheAG2

(strain AJW531),cheAG1/G2 (strain AJW 953) or cheAt1G2 (strain AJW415) at
the center of tryptone swarm plates and, after 6 hr of incubation, compared the
displacements of the outermost edges of their resultant swarms (Fig 9). Wildtype cells (Fig 9A) formed two rapidly migrating concentric bands (0.72 cm h, 1
for the outermost band), indicating that such cells are chemotactic for both Lserine and L-aspartate (Adler 1966). In contrast, cells of each mutant strain
formed dense irregular swarms that migrated at a rate (0.02 cm hr· 1 )
characteristic of nonchemotactic cells that cannot tumble, e.g., the t1cheA strain
AJW1071 (Fig 9B).
To determine whether increased expression of the mutant proteins could
confer chemotactic ability, I transformed the mutant alleles cheAG1, cheAG2,
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WT

A

11cheA

B

Fig 9. Pho tog raphs of representative swarms demonstrating that
wild-type cells (A) form two concentric rings whereas cells deleted for
cheA (B) do not. Cells were inoculated near the center of replicate
trypto ne swarm plates containing 0.2% agar, and the plates were
incubated at 32°C for 6 hr.
experiments ( >1 0).

Experiment is representative of repetitive
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cheAG1/G2, cheA G2, or cheA2FY or cheA2FW (each carried by the IPTGinducable vector pAR 1) into the !lcheA strain AJW1071 . For positive and
negative controls, I also transformed this !lcheA strain with the alleles cheA
and CheA 8 (also carried by the vector pAR1). I inoculated cells of the resultant
transformants at the center of tryptone swarm plates containing 25 µM IPTG
and, after 6 hrs of incubation, compared the displacement of outermost edges of
the swarms. As shown in Fig 10, only cells that expressed both CheAL and
CheA 8 formed two rapidly migrating concentric bands (Panel A). Those that
expressed variants of CheA mutated in G1 (Panel 8), G2 (Panel C), G1/G2
(Panel D), or F (Panel E) formed dense nonchemotactic swarms
indistinguishable from those produced by the cells of AJW1071 alone (Fig 98).
The Inability to Perform Chemotaxis is not due to a Metabolic Defect
The inability of mutants of the putative catalytic domain of CheA to perform
chemotaxis could be due solely to reduced catalytic activity. Alternatively, it
could be due to reduced ability to metabolize serine.

A reduction in the ability

to metabolize an amino acid such as serine would manifest itself as a reduced
growth rate. To distinguish between these possibilities, I transformed the !lcheA
strain AJW1071with pAR1 derivatives that carried the alleles cheA, cheA 8 ,
cheAG1, cheAG2 or cheAG1/G2 (each carried by the IPTG-inducible vector
pAR1 ). I then measured the growth rate of each transformant in TB at 32°C
either in the absence of IPTG or in the presence of
50 µM IPTG. All transformants grew at about the same rate, regardless of IPTG
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cheAG1

C cheAG1 I G2

D

cheAG2

E

F

cheA2FW

cheA

cheA2FY

Fig 10. Photographs of representative swarm patterns demonstrating
that increased expression of plasmid-borne cheA mutants does not restore
chemotaxis to cells deleted for cheA: cells deleted for cheA and
transformed with either pAR1 .cheA (A}, pAR1 .cheAG1 (B), pAR1 .cheAG2
(C), pAR1 .cheAG1/G2 (D), pAR1 .cheA2FY (E), or pAR1 .cheA2FW. All
cells were inoculated in duplicate onto replicate (x 5)TB swarm plates
supplemented with 25 mM IPTG to induce expression of the plasmid-borne
alleles.
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Fig 11. Growth curves demonstrating that cells deleted for cheA ( v) or
deleted for cheA and transformed with pAR 1 derivatives that carry the
alleles cheA ( ■), cheAG1 ('~ ), cheAG2 ( e), or cheAG1/G2 ( □)grow at
about the same rate. Cells were inoculated into TB supplemented with no
IPTG (A) or 50 µM IPTG (B) and incubated at 32oC. This experiment was
performed twice.
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induction (Fig 11).
CheAs. but not CheA 48HQ Restores of Chemotactic Ability to Kinase-Detident
6

CheAL Mutants
CheA 8 lacks the N-terminal 97 amino acids including the site of
phosphorylation (48H). However, it still possesses a functional catalytic
domain. In contrast, variants of the putative catalytic domain of CheAL possess
the site of phosphorylation, but presumably lack kinase activity. CheA functions
as a dimer (Surette et al., 1996). Furthermore, the expression of CheA 8
restores chemotaxis to cells that express the kinase-deficient mutant CheAL470GK, presumably by forming a heterodimer (Swanson et al., 1993; Wolfe and
Stewart 1993). Therefore, to test whether the non-phosphorylatable variant
CheA 8 can also restore chemotactic ability to mutant cells that express other
CheA variants defective in the glycine-rich regions, I transformed the allele
cheA 8 (carried by the vector pAR1) into cells carrying chromosomal copies of

the mutant alleles cheAG1, cheAG2 or cheAG1/G2 (strains AJW955, AJW531 or
AJW953, respectively). Cells of the resultant transformants were inoculated at
the center of tryptone swarm plates containing 25 µM IPTG and, after 6 hrs of
incubation, the displacements of their swarm fronts were compared (Fig 12).
Transformants of strains AJW955 and AJW531 (alleles cheAG1 and cheAG2,
respectively) formed two concentric bands (Panels D and E) that resembled
those of the wild-type strain RP437 (Panel A). The outermost bands, formed by
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these transformants in response to L-serine, migrated about 0.28 cm h 1 and
0.33 cm h-1, respectively.

In comparison, pAR1 .cheA transformants of the

ilcheA strain AJW1071 formed an outermost band that migrated at a rate of
0.49 cm h- 1 (Panel C). In contrast, transformants of strain AJW953 (allele

cheAG 1/G2) formed dense non-chemotactic swarms (Panel F) that migrated as
slowly (0.02 cm h-1) as cells of the ilcheA strain AJW 1071 (Panel B), even when
the concentration of IPTG was increased to as much as 100 µM. Expression of
CheA 8 restores chemotactic ability to cells that express CheA proteins mutated
in either the G1 or G2 regions but not both.
Likely, this occurs because CheA 8 forms a functional heterodimer with each
of the catalytic mutants. The non-phosphorylatable mutant CheAL48HQ was
chosen as a control because, like CheA8 , it possesses an intact putative
catalytic domain and no site of phosphorylation. Since the putative catalytic
domains of CheA8 and CheAL48HQ, are identical, the expression of
CheAL48HQ should also restore chemotaxis to a CheAL protein mutated in the
conserved G 1 and G2 subdomains. I transformed the plasmid pAR 1.cheA48HQ
into cells carrying the mutant alleles cheAG1 (strain AJW955) or cheAG2
(AJW531 ), inoculated cells of the resultant transformants at the center of
tryptone swarm plates containing 25 µM IPTG and, after 6 hrs of incubation,
compared the displacement of their swarms. Transformants of both strains
formed dense, non-chemotactic swarms indistinquishable from those produced
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cheAG2

cheAG1/ G2
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cheA5

cheA5

cheA5
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Fig 12. Photographs of representative swarm patterns demonstrating that
CheAs restores chemotaxis to cells that express the kinase-deficient mutants
CheALG1 or CheALG2 but not CheALG1/G2. Wild-type cells (A, strain RP437),
cells deleted for cheA (B, strain AJW1071 ), cells deleted for cheA and transformed
with pAR1 .cheA (C),cells carrying the allele cheAG1 and transformed with
pAR1 .cheAs (D), cells carrying the allele cheAG2 and transformed with
pAR1 .cheAs (E), and cells carrying the allele cheAG1/G2 and transformed with
pAR1 .cheAs (F). Cells were inoculated at the center of tryptone swarm plates
containing 0.2% agar, and the plates incubated at 32°C for 6 hr (replicate, x5).
Expression of CheA variants was induced with 25 µM IPTG.
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by the parent cells or those of the !!,.cheA strain, AJW1071 (Fig 128). Thus, in
contrast to that of CheA 8 , expression of CheAL48HQ does not restore
chemotactic ability to cells that express CheA proteins defective in either the G 1
or G2 regions.
Similarly, cells that carried the mutant allele cheAG1 transformed with the
allele cheAG2 (carried by the IPTG-inducible vector pAR1) and cells that
carried the mutant allele cheAG2 transformed with the allele cheAG1 (also
carried by pAR1) formed only non-chemotactic swarms that migrated slowly
regardless of IPTG concentration. Thus, CheALG1 and CheAL G2 variants
cannot complement each other in vivo.
Dominance of Various CheA Catalytic Mutants
To determine the effect exerted by the putative catalytic mutants upon the
ability of wild-type CheA to perform its proper function, I explored the possibility
that the phenotypes resulting from these mutations could be explained by an
acquired ability of the mutants to exert a dominant negative effect. I transformed
wild-type cells with the following alleles: cheA, cheAG1, cheAG2, cheAG1/G2,
or cheAAG2 (each carried by the IPTG-inducible vector pAR1 ). Each
transformant was inoculated in duplicate onto the center of replicate swarm
plates containing 25 µM IPTG and their migration rate followed over 6 hrs (Fig
13). Wild-type cells transformed with cheA (panel A), cheA AG2 (panel C),
cheAG1 (panel D), or cheAG1/G2 (panel E) produced a serine band that
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A

ch e A

B

cheAG1

che AG2

cheAt1.G2

E cheAG1/G2

Fig 13. Photographs of swarm plates demonstrating that allele cheAG2
confers a dominant-negative phenotype in a wild-type background. Cells
of the wild-type strain RP437 were transformed with: (A) pAR1 .cheA, (B)
pAR1 .cheAG2, (C) pAR1 .cheMG2, (D) pAR1 .cheAG1, and pAR1 .cheAG1/G2
(E). The transformants were grown to mid-exponential phase in TB and spotted
ontothe center of replicate (x5) tryptone agar plates containing 0.2% agar, 25 µM,
IPTG and incubated at 320c . The displacement of their outermost swarms were
compared after 6 hrs.
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Fig 14. Displacement of the outermost serine band plotted as a function of
time demonstrating the effect of overexpressing plasmid-borne CheA variants
transformed into wild-type cells. cheA mutant catalytic alleles (each carried by the
IPTG-inducible vector pAR1) were transformed into the wild-type background RP437.
Cultures of each strain were inoculated into TB and grown at 320c with aeration
to an O.D.610 of 0.3. Cells were inoculated onto replicate (x5) TB plates containing
( 6) 0, ( •) 25, ( 'v) 50, or ( ♦) 100 µM IPTG and the displacement of their
outermost bands compared over time. Wild-type cells transformed with the IPTG
inducible vector expressing: (A) cheA, (B) cheAG1, (C) cheA.1G2, (D) cheAG2,
(E) cheAG1/G2, (F) cheA2FW, and (G) cheA2FY.
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migrated at rates of approximately 0.22 cm hr -1, 0.28 cm hr1, 0.23 cm hr1, or
0.28 cm hr1 respectively.

In contrast, cells transformed with allele cheAG2·

(Panel B) migrated very slowly relative to the other mutants (0.08 cm hr1 ).
To determine whether increased expression of any of the CheA variants
could either produce or enhance enhance a dominant negative effect, this
experiment was repeated using a range of IPTG concentrations ranging from 0
to 100 µM.
Overexpression of the wild-type cheA allele in a wild-type background
decreases the migration rate in a dose-dependent fashion (Panel A). The
mutant cheA alleles cheAG1 (Panel B) and cheAG1/G2 (Panel E), when
overexpressed in a wild-type background, decrease migration rate in a manner
similar to that observed for overexpression of wild-type cheA. In contrast,
overexpression of the mutant allele cheAG2 (Panel D) exerts a more
pronounced effect on migration rate than observed with overexpression of
either cheAG1, cheAG1/G2 or cheA. CheA~G2 reduces migration rate less
than overexpressed wild-type cheA.

Finally, allelescheA2FY and cheA2FW

seem to exert no effect at all upon migration rate, even when induced at 100 µM
IPTG.
Thus, the allele cheAG2 has a dominant-negative effect upon chemotaxis.
In contrast, both cheA2FY and cheA2FW are recessive mutations. Alleles
cheAG1, cheAG1/G2, and cheA~G2 exert a limited effect upon chemotaxis.
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In Vitro Autophosphorylation Analysis of CheA Variants Defective in

G1, F orG2
Mutations in the transmitter domain of CheA, which alter the conserved
subdomains comprising the putative catalytic site, eliminate the ability to
perform chemotaxis. A catalytic site is distinguished by its ability to bind and
hydrolyze ATP. If the G1, F, and G2 subdomains comprise the catalytic site of
CheA, then CheA variants defective in these regions should fail to autophosphorylate.
To test this hypothesis, I purified each CheA variant and analyzed them for their
ability to autophosphorylate in vitro.
I performed autophosphorylation experiments on wild-type CheAL' wildtype CheA5 , and each mutant protein. Wild-type CheAL, wild-type CheA 5 and
the CheAL mutant proteins CheALG 1, CheAL G 1/G2, CheALG2, CheAi:1G2,
CheAL2FY, and CheAL48HQ, were purified to near homogeneity, as judged by
SOS/PAGE (Fig 15). To ensure that the purified proteins were variants of CheA,
western analysis was performed with CheA-specific antibody (data not shown).
To assess the ability of the CheA variants to autophosphorylate, I added

[y-32 P]ATP to purified preparations of wild-type CheAL' wild-type CheA5 and
each mutant protein. At the conclusion of a 5 min labeling period at room
temperature, the reaction was terminated by the addition of 3X SOS/PAGE
sample-loading buffer, the proteins separated by SOS/PAGE, and the
radioactive bands detected by autoradiography (Fig 16). As expected, the
reaction mixture containing only wild-type CheAL (lane 1) resulted in a
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Fig 15. Purified variant CheA proteins. Proteins were isolated from cells of
strain BL21 (OE3) transformed with various CheA expression vectors, bound
and eluted from His-bind resin, separated by SOS-PAGE (10% gel), and
detected by Coomassie blue staining. Lane (1) wild-type CheAL, lane (2)
wild-type CheAs, lane (3) CheALG1 , lane (4) CheALG1/G2, lane (5) CheALG2,
lane (6) CheALL\G2, lane (7) CheAL2FY, and lane (8) CheAL48HQ. Following
each purification, all proteins were confirmed for purity by SOS-PAGE analysis.
The image was derived by scanning a photograph of the resultant gel with a
Hewlett-Packard Scanjet model lie.
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Fig 16. In vitro autophosphorylation of wild-type and catalytic mutant CheA
proteins. CheA samples (5 µM final concentration of each protein) were
incubated with 50µM [y-32P]ATP (~2500 cpm pmol- 1) in TKMD buffer (see
Materials and Methods), the reactions were terminated by the addition of 3X
SOS-PAGE sample buffer, and the samples were analyzed by SDS/10% PAGE
followed by autoradiography for 60 min. Lane 1, wild-type CheAL; lane 2,
wild-type CheAs; lane 3, CheALG1; lane 4, CheALG2; lane 5, CheALG1/G2; lane
6, CheAL2FY; lane 7; CheAL48HQ; and lane 8, CheAL L\G2.
The image was derived by scanning a photograph of the resultant gel with a
Hewlett-Packard Scanjet model lie.
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radiolabeled protein of MW about 78-kDa. in contrast, the reactions containing
the following CheA variants did not result in such a band: CheA 8 (lane 2),
CheALG1 (lane 3), CheALG2 (lane 4), CheALG1/G2 (lane 5), CheAL2FY (lane6),
CheAL 48HQ (lane 7), or CheAL LiG2 (lane 8). Thus, unlike wild-type CheAL,
wild-type CheA8 and the mutant proteins did not autophosphorylate.
ATP Binding
On the basis of sequence homology with ATP binding motifs identified in
eukaryotic serine/threonine kinases, Parkinson and Kofoid (1992) proposed
the glycine-rich regions of the transmitter domain to be the site of ATP binding.
However, no study has identified conclusively that this region actually binds
ATP. My first attempt to address this problem ended in failure. I attempted to
cross-link [a-32 P]ATP to CheA using UV light. The resulting adducts were
separated by SOS-PAGE and visualized by autoradiography. All of the
proteins, both wild-type and mutant forms, seemed to bind ATP (data not
shown). To determine if such binding was specific or not, I attempted to
interfere with the ability of wild-type CheA to bind [a-32 P]ATP by pre-incubating
CheA with 100-fold excess non-radioactive ATP. This excess unlabeled ATP
failed to eliminate labeled ATP binding. I concluded that this method may
encourage non-specific binding of ATP.
Subsequently, we established a collaboration with Richard Stewart
(University of Maryland). To determine if mutagenesis of the putative catalytic
domain had an effect on nucleotide binding, the fluorescent ADP analog, TNP-

69
ADP, was titrated against 10 µM of wild-type CheA and that of CheAL G 1,
CheALG2, CheALG1/G2 or CheAL~G2. (according to the method of White and
Dewey, 1987). The increase in fluorescence was measured and the data
plotted as fluorescent intensity as a function of TNP-ADP concentration of the K0
calculated (Table 4). The mutants CheALG1 or CheALG2, CheALG1/G2, and
CheAL~G2 bound TNP-ADP with a significantly reduced affinity relative to that
of wild-type CheAL (K 0 of 60 µM, 110 µM, 16 µM, and 5 µM respectively).

In

contrast, CheAL G2 bound TNP-ADP about as well as wild-type CheA (K 0 of 6
µM).
Thus, the G 1 region of CheA appears to be intimately involved in nucleotide
binding whereas the G2 region does not.
The Non-Phosphorylatable Variants CheA:S and CheA.L48HQ can Mediate
Transphosphorylation of Kinase-Deficient CheA.L Mutants In Vitro
To assess the ability of the non-phosphorylatable CheA variants, CheA8
or CheAL48HQ, to promote phosphorylation of the CheA putative catalytic
mutants CheALG 1, CheALG2, CheAL G 1/G2 and CheAL~G2, [y- 32 P]ATP was
added to purified preparations of wild-type CheAL or wild-type CheA 8 or each
mutant protein which had been pre-incubated for 30 min in the presence of
either CheA 8 or CheAL48HQ. At the conclusion of a 30-min labeling period at
room temperature, the reaction was terminated by adding 3X SOS-PAGE
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Table 5.--TNP-ADP binding affinities of
CheAL proteins
Protein

Ko

CheAL(WT)

5µM

CheALG1

60µM

CheALG2

6µM

QieALG1/G2

110 µM

CheAL~G2

16µM

sample-loading buffer and the results analyzed by SOS-PAGE and
autoradiography.

Reactions containing wild-type CheAL alone or both CheA8

and any of the following CheA mutants resulted in a radiolabeled protein of MW
about 78-kDa: CheALG1 (lane 1), CheALG2 (lane 2), CheALG1/G2 (lane 3) and
CheAL~G2 (lane 4). In contrast, reactions containing only CheA did not.
8

Interestingly, reactions performed with CheA 8 repeatedly resulted in more
radiolabeled CheALG1 or CheALG2 (about 6% of wild-type levels) than
radiolabeled CheAL G 1/G2 or CheAL~G2 (about 1.5% of wild-type levels).
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+ CheA5 (5 µM)

5µM

A
+ CheAL48HQ (5 µM)

5µM

B
Fig 17. In vitro assays demonstrating that the non-phosphorylatable proteins
CheAs (A) and CheAL48HQ (B) can mediate transphosphorylation of kinase
deficient mutants of CheAL. CheA samples containing 5µM [final co-ncentration]
of either CheAL or CheAs or both CheAs and each mutant protein or
CheAL48HQ and each mutant protein were pre-incubated for 30 min in TKMO
buffer (see Materials and Methods) before the addition of 50µM [y- 3 2 P]ATP
(~2500 cpm pmol-1). The reactions were terminated after 30 min by the addition
of 3X SOS-PAGE sample buffer and the samples were analyzed by SOS-PAGE
(10%) followed by autoradiography for 60 min. Two radiolabeled bands were
observed: one of about 78 kOa and a second, of about 30 kOa. Only the 78 kOa
band is shown. Counts within this 78 kOa band were collected for 1 hr with a
Betascope 603 blot analyzer within the linear range of the instrument. The
experiment was performed 3 times.
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Similarly, reactions containing both CheAL48HQ (Panel B) and each of the

cheA mutants resulted in a radiolabeled protein MW 78 kOa. The intensity of
the signal however, was substantially reduced compared to the levels observed
for CheA 8 . Again, the amount of radiolabelled CheAL G1 or CheAL G2 was
greater than the amount of radiolabelled CheAL G 1/G2 or CheAL~G2
To assess the ability of the mutant proteins CheAL G1 and CheAL G2 to
promote phosphorylation of each other, I added [y-32 P]ATP to purified
preparations of wild-type CheAL alone, CheAL G1 alone, CheAL G2 alone, both
CheAL G 1 and CheAL G2, or CheAL2FY alone that had been preincubated for
30 min (Fig 18). At the conclusion of a 30-min labelling period at room
temperature, the reaction was terminated by adding 3X SOS-PAGE sampleloading buffer and the results analyzed by SOS-PAGE and autoradiography. In
contrast to reactions containing wild-type CheAL alone (lane 1), those
containing CheAL G1 alone (lane 2), CheAL G2 alone (lane 3), both mutant
proteins together (lane 4), or CheAL2FY alone did not result in a radiolabeled
78-kOa protein.

Reactions performed with both CheAL G 1 and CheALG2

together (Lane 4) resulted in very poor phosphorylation of a protein that
migrated more slowly than wild-type CheAL. For several reasons, it seems
unlikely that this band corresponds to a phosphorylated form of either CheAL G 1
or CheAL G2 or of their 6XHis-tagged variants. First, the phosphorylated forms
of CheAL G1 and CheAL G2 migrate with the same mobility as phosphorylated
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wild-type CheAL. Second, after cleavage with thrombin, we detected no 6Xhis
CheA variant by immunoblot analysis. Third, we detected no phosphorylation of
the 6X-His tag itself when fused to either of the nonphosphorylatable proteins,
CheA 8 and CheAL48HQ (data not shown).
These results are consistent with a model by which the G1 and G2
subdomains within the TR of one protomer of a CheA dimer form a unit that
mediates transphosphorylation of the other protomer within that dimer.
Interestingly, reactions involving CheAL G1 (lanes 2 and 4) yielded a
radiolabeled protein fragment of MW about 30-kDa. We observed a
phosphorylated fragment of similar molecular weight in reactions involving
wild-type CheAL alone (lane 1) or the F mutant, CheAL2FY (lane 5). To
determine whether the observed fragments included the site of phosphorylation,
His-48, we performed immunoblot analyses using anti-CheA (Fig 19a) or
anti-CheAL antisera (Fig 19b). Wheras CheAL and the 30-kDa fragment
reacted with both antisera (lanes 1 and 3 respectively), CheA 8 reacted with only
the anti-CheA serum (lanes 2). On the basis of its size (30kDa),
immunoreactivity with antisera specific for an epitope unique to the P1
domain, and the ability to accept a phosphoryl group, I have concluded that this
degradation product corresponds to a previously reported CheA fragment
composed of the N-terminal P1 and P2 domains (Oosawa et al., 1988).
Thus, although the G1 and F mutants cannot autophosphorylate, they seem
to be able to mediate transphosphorylation of the P1 -P2 fragment. ·In contrast,
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Fig 18. Phosphorylation of CheAL variants. CheA samples (each protein at 5
µM [final concentration]) were pre-incubated for 30 min in TKMO buffer (see
Materials and Methods) before the addition of 50µM [y-3 2P]ATP (~2500 cpm
pmol-1). The reactions were terminated by the addition of 3X SOS-PAGE
sample buffer and the samples were analyzed by SOS-PAGE (10% gel)
followed by autoradiography for 60 min. Lane 1, wild-type CheAL; lane 2,
CheAL G 1; lane 3, CheAL G2; lane 4, CheAL G 1 and CheAL G2; lane 5,
CheAL2FY. Arrow indicates position of 30 kOa degradation product. The image
was derived by scanning autoradiographs with a Hewlett-Packard Scanjet
model lie.
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Fig 19. lmmunoblot analyses using antisera specific for CheAL and CheAs
(A) or CheAL alone (B) as primary antibodies. (A) lane (1 ), 6XHis-CheAL;
lane (2), 6XHis-CheAs; lane (3), 6XHis-CheAL incubated at room
temperature for 5 days at room temperature. (B) Lane (1 ), 6XHis-CheAL;
lane (2), 6XHis-CheAs, lane (3), 6XHis-CheAL incubated at room
temperature for 5 days to permit degradation and reabsorbed over His-bind
resin (Novagen) to enrich for P1 containing fragments. The image was
derived by scanning the immunoblots with a Hewlett-Packard Scanjet model
lie. r
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Fig 20: Computer algorithm analysis of secondary structure of the
transmitter domain of CheA. Secondary structure is expressed as (E)
sheet, (C) coil , (L) loop, (H) helix, (T,S) turn.
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the G 1 mutant seemingly cannot.
Structure Averaging Algorithms
In contrast to a number of serine/threonine kinases (Lima, et al. 1996,
Owen, et.al. 1995; Emerson, et al. 1995; Owen, et al. 1995), there is little or
no structural information about the putative catalytic domain of CheA. In the
absence of such structural information, I made use of several structure
averaging algorithms to derive information about the possible secondary
structure of this domain (Fig 20). One of the algorithms, the PhD method,
was used to test the accuracy of the program by comparison of the published
NMR structures of the P1 and P2 domains with the predicted structure. The
PhD method revealed a level of agreement of about 64%.
CheA237-519
The observation that the G2 mutation confers stability and solubility to
CheA led to me to believe that this mutation might increase the solubility of
the isolated transmitter domain, thereby enabling NMR spectroscopic
analysis of this highly insoluble domain. To test this possibility, I generated
a truncated CheA protein, by introducing an Nde I site into the linker region
between domains P2 and T. This involved two amino acid substitutions
(P236H, V237M) which, interestingly, had no effect upon chemotaxis when
compared to wild-type (data not shown). Into this construct, I then introduced
both the G2 mutation and a premature stop codon in the linker region
between T and M. This construction, called pDECheA237-519 (pDE36),
was subcloned into pET14b, expressed, purified, and concentrated to 6
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mg/ml. Solubility, in the context of NMR spectroscopy, refers to the ability of
the protein, in high concentration and in an appropriate buffer, to resist
precipitation when incubated at room temperature. CheA237-519 was
judged soluble by virtue of its ability to stay in solution at both room
temperature and at 4°C overnight when at a concentration of 6 mg/ml. The
pDE36 construction was sent to Rick Dahlquist (University of Oregon) and is
currently being assessed by Megan McEvoy (University of Oregon) as a
candidate for NMR spectroscopy. If successful, this would be the first NMR
spectroscopic analysis of a histidine kinase transmitter domain. Other, more
conservative mutations in G2 are being generated in an attempt to mimic the
degree of solubility observed in the G2 mutant. The enhanced stability and
solubility of CheAL G2 and its ability to bind ATP with about wild-type affinity,
has led us to consider it as a candidate for x-ray crystallography.

CHAPTER 5
DISCUSSION AND SUMMARY

To identify regions of the CheA transmitter domain required to perform its
catalytic activity, I constructed a select group of CheA mutants. I tested each of
the mutants for their ability to perform chemotaxis in vivo and to
autophosphorylate and/or to be transphosphorylated in vitro. Finally, I
measured the ability of a subset of these mutants to bind ATP and/or to facilitate
clustering of ternary complexes.
Mutagenesis Strategy
There are few studies that explore the relationship between structure and
function of the putative catalytic regions of two-component histidine kinases.
Since the putative catalytic domain of such kinases are insoluble at high
concentrations, x-ray crystallographic and NMR spectroscopic studies to
determine the structure have not been possible. Therefore, I used mutations as
a tool to hypothesize about what this region of CheA might look like and how it
functions.
The G 1 and G2 regions of CheA resemble the kinase 2 and kinase 1
regions of several bacterial kinases (Matte et al., 1996; Muller and Schulz,
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1993; Reinstein et al, 1990; and Rose et al., 1991 ). Glycines are known to react
with the nucleotides AMP and ATP (Yoneya et al., 1989). The consensus
kinase 1 motif of E. coli phosphoenolpyruvate kinase (PCK) and adenylate
kinase is G-X-X-G-X-G-K-T. This closely resembles the GXGXG motif of the G2
subdomain of CheA. The kinase 2 region contains the consensus motif

X-X-X-X-D (L-I-G-D-D in PCK) (Traut, 1994). The conserved "D" forms a Mg2+
binding site in conjunction with one of the hydrophobic "X" residues (Matte et
al., 1996). The kinase 2 region of these proteins closely resemble the G1
region of CheA (DDGAG), except that the "D" residue in CheA is N-terminal
rather than C-terminal.
We decided that the best mutation was one which should exert little
structural impact on the region of interest, while changing the ability of that
reactive amino acid to interact with either its nucleotide or other functional
components of the putative catalytic domain. For instance, changing a
phenylalanine to a tyrosine maintains the aromatic nature of the amino acid but
adds a reactive hydroxyl group to the aromatic ring. This type of strategy has
been used previously to determine the identity of amino acids reactive to the a,
~. and yphosphoryl groups of ATP (Bazaes et al., 1993, 1995).
Mutations in ATP binding regions which change glycine to some other
residue have repeatedly been shown to alter catalytic function in kinases
(Yoneya et al., 1989; Ninfa et al., 1993). We chose to change conserved
glycines in the G 1 and G2 subdomains of CheA because this change presented
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the least possibility of causing structural alterations in the region. A change
from glycine to alanine replaces the reactive H with a methyl group but
maintains the aliphatic identity of this residue. Despite proline being "aliphaticlike", it was eliminated as a possible replacement for the glycine residues
because the G1 and G2 regions are predicted to be flexible loops and the rigid
backbone of proline could have perturbed the interaction of these putative loops
with neighboring structures. Three crystallographic studies and one functional
study performed on conserved glycine residues in the nucleotide binding
regions of E. coli adenylate kinase reinforce the decision to replace glycine
residues with alanines. Muller and Schulz (1993) demonstrated that
replacement of glycine-10 with valine hinders the induced fit movements of the
active site. This suggests that this type of substitution could perturb structure in
an ATP binding loop. Reinstein et al. (1990) clearly showed that a glycine-10 to
valine substitution has an increased dissociation constant for substrate and
structural alterations in the nucleotide binding site. Rose et al. (1991) showed
that a glycine 85 to valine substitution in the kinase-2 region of E. coli
adenylate kinase caused a decrease in the thermodynamic stability of the
protein. Finally, Yoneya et al. demonstrated that a glycine 15 to alanine or a
glycine-20 to alanine substitution in E. coli adenylate kinase decreased the
affinity of the kinase-1 region for AMP and ATP.
Chemotaxis Requires Intact G1. F. and G2 Subdomains
The mutations 422GA, 455FY/459FY, 455FW/459FW,
470GA/472GA/474GA and ~(468-476), located within the highly conserved G1,
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F, and G2 regions of the histidine kinase CheA, each eliminated the ability of
cells to perform chemotaxis. The G2 mutation 470GK also eliminates
chemotaxis (Oosawa et al., 1988). Mutations in G1, F, and G2 in other histidine
kinases yield similar results. For example, a mutation in the G2 region of NRII
reduces the ability of cells to activate expression of glnA (Ninfa et al., 1993).
Similarly, a mutation that deletes the F and G2 regions of DctB eliminates the
ability of that protein to functon in vivo (Giblin et al., 1996).
Autophosphorylation Requires Intact G1, F. and G2 Subdomains
To determine why these mutant alleles failed to support chemotaxis in
vivo, I measured the ability of each purified mutant protein to

autophosphorylate.

In contrast to wild-type CheAL' none of the putative

catalytic mutants tested autophosphorylated when incubated in the presence of
[y-32 P]ATP for up to 30 minutes. Other researchers also have shown that
mutations in the conserved subdomains inhibit the ability of CheA and other
histidine kinases to autophosphorylate. Mutations which truncate the catalytic
domain at either the 503'rd position or change residue G470 to a K eliminate
the ability to autophosphorylate (Wolfe and Stewart, 1993; Swanson et al.,
1994). Similarly, mutations that truncate the F and G2 regions of DctB (Giblin et
al., 1996) and those that alter the G2 domain of NRII severely perturb the ability
of these proteins to autophosphorylate (Ninfa et al., 1993).
The CheALG2, CheAL~G2, and CheALG1/G2 mutants were more stable
than the wild-type CheAL protein. In contrast, the CheALG1 mutant was less
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stable than wild-type CheAL. Thus, the lack of stability in these mutants could
account for the inability of CheAL G 1 to autophosphorylate and mutant cells
expressing this protein to perform chemotaxis.

In the case of the CheAL G 1

mutant however, this is unlikely because CheA 8 can mediate
transphosphorylation of CheAL G 1. The same cannot be said for the F mutants.
In contrast to CheAL G 1 and in particular CheAL G2 and CheALLiG2 the F
mutants were very unstable in vitro. The lack of autophosphorylation may be an
artifact of such instability.
Since purification of CheA and variants of CheA involves the absorption
of a total cell lysate of BL21 (DE3), an E. coli strain, phosphatases to CheA such
as CheB or CheY could have co-precipitated with CheA in the eluate, despite
stringent washing of the Ni 2+ absorption column. Autophosphorylation
experiments performed with fresh preparations of wild-typeCheA, however,
revealed no radiolabelled bands corresponding to the molecular weights of
CheB or CheY. Similarly, no contaminating bands were ever observed upon
SOS-PAGE analysis of freshly purified preparations of CheA and variants of
CheA. Despite these observations, it is possible that very small quantities of
CheY and CheB contaminants were in the purified preparations of CheA and
CheA variants. The level of disparity of phosphorylation between wild-type
CheA and CheA variants, however, demonstrates that whatever influence the
possible contaminants had on the ability of the CheA variants to
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autophosphorylate was minimal. Thus, we conclude that the inability of G1 and
G2 mutants to perform chemotaxis likely results from their inability to
autophosphorylate.
G1 Residue G422 Plays an Intimate Role in Binding of ATP: G2 Residues G470,
G472, and G474 do not
To autophosphorylate, CheAL must first bind ATP. Therefore, quantitative
nucleotide binding studies were performed on the G 1, G2. G 1/G2 and ~G2
mutants of CheAL. Intriguingly, CheAG2 bound TNP-ADP about as well as wildtype. In contrast. CheAL G1 bound TNP-ADP poorly.
However, we conclude that G 1 is intimately involved in the binding of
adenine-containing nucleotides. Conversely, we can conclude that G2 is not.
Evidence exists, however, that this latter region may play a secondary role in
such binding. The CheAL~G2 mutant has had all of the conserved residues
removed, including those flanking the conserved glycines. In contrast. the
CheALG1/G2 mutant retains the conserved residues flanking G2. If the G1
region was solely responsible for binding TNP-ADP, then one might expect that
the level of nucleotide binding in the ~G2 region would approximate that
observed in the G2 mutant. In addition, the double CheAL G1/G2 mutant might
also be expected to bind nucleotide with about the same affinity as CheAL G 1.
This is not the case. Both CheAL~G2 and CheALG1/G2 bound TNP-ADP with a
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lower affinity than predicted. These reduced binding affinities suggest two
possibilities. Either the G2 region contains other conserved residues (perha·ps
those flanking it) which could be involved in nucleotide binding or these
mutations cause structural perturbations by not allowing nucleotide-binding
residues in G2 to interact with the remaining nucleotide-binding residues in G 1.
Secondary structure prediction methods (see below) suggest that the in-frame
removal of nine amino acids in the CheAL~G2 mutant would eliminate a
predicted G2 loop structure and render the region from F through the the G2
region a helix. This suggests that a structural perturbation and the removal of
critical nucleotide-binding residues may be responsible for the reduced
nucleotide-binding observed in this mutant.
The interpretation of these results must take into account that the affinity
of CheA for TNP-ADP is significantly greater than the affinity of CheA for ADP or
ATP (K

0

5 µM, 50 µM, or 300 µM respectively). This fact must be taken into

account when considering this data.

In the absence of ATP competition

binding experiments, we cannot draw any conclusions concerning binding
affinity of these mutants for nucleotide.
G2 Residues G470, G472. and/or G474 Play a Role in either the Docking of P1
and/or the Subsequent Phosphotransfer: G1 Residue G422 and F Residues
F455 and F459 do not
To autophosphorylate, CheA must facilitate the interaction between
bound ATP, the site of phosphorylation, and phospho-transfer. The P1 domain
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receives its phosphate from the catalytic site. Autophosphorylation experiments
demonstrated that the catalytic domains of the unstable G 1 and F mutants
efficiently transphosphorylated a 30 kDa degradation product comprised of the
P1 and P2 domains even though full length protein could not
autophosphorylate. Since the G 1 and F mutant proteins transphosphorylate the
P1-P2 fragment, the ability of these proteins to interact with P1 must not be
significantly affected. In contrast, the G2 mutant could not transphosphorylate
the degradation product.

The apparent inability of this mutant protein to

transphosphorylate the 30 kDa degradation product could be explained if the
G2 mutation conferred gross structural defects. This is unlikely, however, since
CheAL G2 binds ATP as efficiently as wild-type CheA. Thus, the G2 region may
play a role in docking of the P1 domain to the catalytic site. Alternatively, it
could function in subsequent phosphotransfer. At present, I cannot distinguish
between these two possibilities. However, the fact that G2 seemingly is not
required for nucleotide binding yet seemingly is necessary for subsequent
events suggests that G1 and G2 each play different roles in the catalytic
process.
Clustering of Ternary Complexes Requires an Intact G2 Subdomain, but not a
G 1 Subdomain
Intriguingly, mutants defective in G2 do not form polar aggregates (J.
Maddock, personal communication). The lack of aggregates resembles that of
mutants entirely lacking CheA, CheW, or MCPs. The simplest explanation for
these results is that G2 does not form ternary complexes. At present, this is only
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a hypothesis. Careful in vitro binding studies will be required to establish
whether CheAL G2 can couple into a ternary complex.

In contrast, mutants in

the G1 subdomain do form aggregates. Therefore, the G1 mutant must form
ternary complexes.
Ternary complex formation in vivo must not be closely associated with
the ability to bind ATP. The G1 mutant binds TNP-ADP poorly yet forms ternary
complexes, while the G2 mutant binds TNP-ADP well yet does not form ternary
complexes. These in vivo results fit well with the observation by Gegner et al.
(1992) that ATP is not necessary for ternary complex formation in vitro.
These observations could be explained if the G2 subdomain is one of the
sites through which the ternary complex affects the hydrolysis of ATP and the
subsequent phosphotransfer by bringing G2 close to G 1 to form a functional
catalytic site. If G2 is a docking site for the P1 domain, then this arrangement
would make sense. This is only speculation, however, and there could be
alternate explanations for these results. This hypothesis could be tested, in
part, by performing studies which quantitate the binding affinity of the 30 kDa
P1/P2 domains for each of the mutants and comparing that to the binding affinity
of the P1/P2 domains for wild-type CheA. An interesting experiment might be to
do the binding studies in a ternary complex composed of each catalytic mutant,
CheW, and chemoreceptor cytoplasmic domains which have their methylation
sites altered to place the ternary complex in the "on" or "off " states. If G2 is a
docking site for the P1 domain, then a chemoreceptor in the "off" state might
have a lower affinity for the P1 domain since the docking site would be
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sequestered.
G1 and G2 Function in cis
CheA functions as a dimer (Surrette et al., 1996). The P1 domains of
each protomer obtain their phosphate in trans from their dimer partner (Wolfe
and Stewart, 1993). There are two possible ways in which the G1, F, and G2
subdomains of the transmitter domains in a CheA dimer could function. First,
they could function in trans. That is, they could each contribute subdomains to
form one functional catalytic unit. Second, they could function in cis as
structurally independent catalytic subunits.
I performed a series of in vitro complementation experiments in which
purified preparations of several CheA catalytic mutant proteins were mixed
together and their respective levels of phosphorylation assayed in the presence
of [y- 32 P]ATP. Additionally, I performed a series of in vivo experiments in which
various catalytic mutants of CheA , placed in single copy on the chromosome,
were complemented with a wild-type catalytic domain provided by CheA5 .
In vitro, the short form of CheA transphosphorylated all of the CheAL
catalytic domain. The level of transphosphorylation by CheA 5 of the CheALG1
and CheALG2 mutants was about 6% that of wild-type CheAL
autophosphorylated under the same conditions. In contrast, the level of
transphosphorylation of CheAL G 1/G2 or CheAL~G2 was about 1% that of
wild-type CheAL. In vivo, CheA5 complemented only variants mutated in G1 or
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G2 alone. It could not complement the double mutation (CheAL G 1/G2) or the
mutation in which the entire G2 region has been removed in-frame. The
inability of these latter mutants to be complemented in vivo is likely to be due to
the low level of CheA8 -mediated phosphorylation observed in vitro. The
disparity between the levels of phosphorylation required for CheA 8 -mediated
chemotaxis and the wild-type levels of phosphorylation in vivo seems to
indicate that a minimum threshold of phosphorylation is required to drive
chemotaxis. Evidence exists for such a phenomenon: a P1 deletion mutant can
be complemented in trans only if P1 is provided in excess (Garzon and
Parkinson, 1996). If the level of phosphorylation drops below that minimum
threshold, then the efficiency of phospho-transfer to CheY, even when the
mutant protein is bound into the ternary complex, is too low to mediate
chemotaxis. If the level of phospho-CheY is too low to overcome spontaneous
degradation or CheZ-mediated dephosphorylation, the cells will rarely tumble.
The predominately smooth swimming behavior of these mutants has been
confirmed by light microscopy under a variety of induction conditions.
In vivo, CheAL G1 and CheALG2 could not complement each other. In
vitro, the combination of CheALG 1 and CheAL G2 resulted in a poorly
phosphorylated product that migrated slightly slower than the
78 kDa full length wild-type CheA protein. For several reasons, it seems
unlikely that this band corresponds to a phosphorylated form of either CheALG 1
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or CheAL G2. First, the phosphorylated forms of CheAL G1 and CheAL G2
migrated with the same mobility as wild-type CheAL. Second, after cleavage
with thrombin, no 6XHis-CheA variant was detected by immunoblot analysis.
Third, we detected no phosphorylation of the 6XHis tag itself when fused to
either of the non-phosphorylatable proteins, CheAs, or CheA48L HQ.
These results are consistent with a mechanism by which the G1 and G2
subdomains within the TR of one protomer of a CheA dimer form a unit that
mediates transphosphorylation of the other protomer within that dimer. This
model easily reconciles with that of Tawa and Stewart (1994) who
demonstrated that at least one residue (i.e., 337P) in the TL of the protomer that
becomes phosphorylated helps to determine the binding affinity of CheA for
ATP. One can envision a model in which the TL of one protomer interacts with
the TR of the second protomer within the dimer to modulate ATP-binding and
hydrolysis.
Secondary Structure Prediction and Model for the Structure of the Catalytic
Domain of the Histidine Kinase CheA
Secondary structure algorithms, while far from perfect as a replacement
for structural visualization methods such as NMR spectroscopy and
x-ray-crystallography, can be helpful when trying to correlate data derived from
in vitro and in vivo analysis to functional models. With this kind of knowledge in
hand, an initial test can be performed which allows a researcher to generalize
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about what the secondary structure of any particular protein may look like. As an
initial analysis, these algorithms take short stretches of amino acids (approx. ·
30 aa or smaller) and attempt to find similar structures within proteins that have
already been crystallized. The protein data bank (PDB) contains the three
dimensional structures of several hundred proteins. Many proteins are highly
flexible, assuming different shapes in the presence or absence of antigen,
ligands, metals, or nucleotides. This type of structural mobility has been
observed when crystallographic structures were compared between different
binding states. When protein motifs on file in the PDB are found to be
homologous to the protein being analyzed, the predictions derived from
algorithms such as these can be quite accurate. Using the CheA primary amino
acid sequence as a template, I used several algorithms in an attempt to derive
secondary structure information over the entire protein. Since it is the focus of
this study, the putative ATP binding region of transmitter domain was of
particular interest. To predict the secondary structure of this region, 5 different
algorithms were utilized (Gilbrat et al., 1987, Levin et al., 1986, Deleage and
Roux, 1987, Rost and Sander, 1994, Geourjon and Deleage, 1995). Based
upon such factors as sequence homology, side chain associations, and solvent
accessibility, a consensus of the methods predicts that G1, F, and G2 resemble
coils and turns (loops). In a separate secondary structure analysis of this region
using only the PhD prediction method, these regions are predicted to be
unstructured loops, consistent with observations of the crystallographic structure
of several different eukaryotic ATP binding regions. F is flanked by alpha
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helices and sheets that suggest a bend, As a reference for the accuracy of
prediction of each of these methods, the predictions were compared to the
deduced structure of the N-terminal domains P1 and P2 of CheA. These
domains have undergone rigorous analysis by NMR and their 2° and 3°
structures are known.
On the basis of these structure-averaging algorithms, we propose that the
catalytic region is best represented as a cleft in which the F subdomain lies at
the base and acts as a flexible turn or hinge flanked by two short alpha helices
(Fig 20). This arrangement would serve to approximate G1 and G2, predicted to
be unstructured ATP-binding loops (Rossman and Liljas, 1974). The binding of
ligand by the chemoreceptor would initiate a cascade through the ternary
complex with the end result being the movement of the G1 and G2 loops apart,
rendering CheA in an inactive conformation. Release of ligand would remove
this repression permitting the catalytic domain to return to the active
conformation in which G 1 and G2 properly align relative to one another.
Significance of Other Histidine Kinases that lack Some of the
Conserved Regions
In undertaking this study, I was interested in defining the structure and
function of a little understood region of the histidine kinase CheA. Although this
study was concerned with the putative catalytic domain of one protein, the
motifs which define CheA as a histidine kinase are shared by many other
proteins. Over 100 two-component histidine kinases have been identified in
bacteria. Several have also been identified in eukaryotes and plants (Ota and
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Fig 21. Model for the structure of the G1 - G2 region of the transmitter domain of
CheA. The catalytic site is represented in this model as two ATP binding loops
(G1 and G2) separated by two beta-pleated sheets and a bend at the F box.
The site is in an "active" form when the two loops are allowed to approximate
into a single, functional catalytic site. The catalytic site is in an "inactive" form
upon dissociation of G 1 and G2.
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Varshavsky, 1993 Chang, et.al., 1993) suggesting that this type of kinase is not
unique to either prokaryotes or even to single-celled organisms. Structural
information about the catalytic region of any histidine kinase is a much desired
goal of many different groups of researchers. In addition to its obvious
intellectual value, catalytic domain structural information has enormous
potential forpractical value as well.

Since the general catalytic motif of histidine

kinases has mostly been observed in bacteria, a number of which are
pathogenic to humans and animals, it has important potential as
a therapeutic target. Several companies, including one our lab has been in
collaboration with, are interested in designing drugs which would interfere with
the function of this domain.
Not all putative catalytic domains of histidine kinases have the N, G1,
F, G2 arrangement of all four catalytic subdomains. The nitrate/nitrite sensor
protein NarX, for instance, lacks both the F and G2 regions. Yet, it mediates
phosphorylation and dephosphorylation of the response regulator NarL
(Schroder et al., 1994; Chiang et al., 1992). The Bacillus subti/us histidine
kinase DegS also lacks the G2 region. In addition, its F subdomain seems to be
in the orientation opposite to that of the conventional histidine kinase motif. It
too can mediate phosphorylation of a response regulator DegU (Hanner et al.,
1988).

The absence of catalytic motifs in these other histidine kinases should be
noted since they may help us understand the function of particular subdomains.
Clearly, further structure-function investigations such as this are necessary.
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